# EDGAR Filing Document

**Accession Number:** 0000067887
**File Stem:** 0000067887-25-000051
**Filing Date:** 2025-7
**Character Count:** 151509
**Document Hash:** 57571a626d733a59c45bcb32f0707a1d
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000067887-25-000051.hdr.sgml**: 20250725

**ACCESSION NUMBER**: 0000067887-25-000051

**CONFORMED SUBMISSION TYPE**: 10-Q

**PUBLIC DOCUMENT COUNT**: 110

**CONFORMED PERIOD OF REPORT**: 20250628

**FILED AS OF DATE**: 20250725

**DATE AS OF CHANGE**: 20250725

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** MOOG INC.
- **CENTRAL INDEX KEY:** 0000067887
- **STANDARD INDUSTRIAL CLASSIFICATION:** MISC INDUSTRIAL & COMMERCIAL MACHINERY & EQUIPMENT [3590]
- **ORGANIZATION NAME:** 06 Technology
- **EIN:** 160757636
- **STATE OF INCORPORATION:** NY
- **FISCAL YEAR END:** 0927

**FILING VALUES:**
- **FORM TYPE:** 10-Q
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-05129
- **FILM NUMBER:** 251150206

**BUSINESS ADDRESS:**
- **STREET 1:** 400 JAMISON ROAD
- **CITY:** EAST AURORA
- **STATE:** NY
- **ZIP:** 14052
- **BUSINESS PHONE:** 716 652 2000

**MAIL ADDRESS:**
- **STREET 1:** 400 JAMISON ROAD
- **CITY:** EAST AURORA
- **STATE:** NY
- **ZIP:** 14052

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** MOOG INC
- **DATE OF NAME CHANGE:** 19920703

?xml version='1.0' encoding='ASCII'? mog-20250628

<u>[**Table of Contents**](#ie7d2cf4f294a4c48b9da5fb075e0f93b_7)</u>

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 10-Q** 

**(Mark One)**

☒ **QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**

**For the quarterly period ended June 28, 2025** 

**OR**

☐ **TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**

**For the transition period from _________ to _________**

**Commission file number 1-05129** 

**MOOG Inc.** 

**(Exact name of registrant as specified in its charter)**

---

| | | | |
|:---|:---|:---|:---|
| **New York** | **New York** | | **16-0757636** |
| (State or other jurisdiction of incorporation or organization) | (State or other jurisdiction of incorporation or organization) | | (I.R.S. Employer Identification No.) |
| **400 Jamison Road** | **East Aurora,** | **New York** | **14052-0018** |
| (Address of Principal Executive Offices) | (Address of Principal Executive Offices) | (Address of Principal Executive Offices) | (Zip Code) |

---

**(716) 652-2000** 

(Registrant's telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
| Class A common stock | MOG.A | New York Stock Exchange |
| Class B common stock | MOG.B | New York Stock Exchange |

---

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.&nbsp;&nbsp;&nbsp;&nbsp;Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). &nbsp;&nbsp;&nbsp;&nbsp;Yes ☒ No ☐

------

<u>[**Table of Contents**](#ie7d2cf4f294a4c48b9da5fb075e0f93b_7)</u>

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.

---

| | | | |
|:---|:---|:---|:---|
| Large accelerated filer | ☒ | Accelerated filer | ☐ |
| Non-accelerated filer | ☐ | Smaller reporting company | ☐ |
| | | Emerging growth company | ☐ |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). &nbsp;&nbsp;&nbsp;&nbsp;Yes ☐&nbsp;&nbsp;&nbsp;&nbsp; No ☒

The number of shares outstanding of each class of common stock as of July 18, 2025 was:

Class A common stock, 28,423,926 shares

Class B common stock, 3,253,885 shares

------

<u>[**Table of Contents**](#ie7d2cf4f294a4c48b9da5fb075e0f93b_7)</u>

![moogimage2a16.jpg](mog-20250628_g1.jpg)

**QUARTERLY REPORT ON FORM 10-Q**

**TABLE OF CONTENTS**

---

| | | | |
|:---|:---|:---|:---|
| **<u>[PART I](#ie7d2cf4f294a4c48b9da5fb075e0f93b_10)</u>** | **<u>[FINANCIAL INFORMATION](#ie7d2cf4f294a4c48b9da5fb075e0f93b_10)</u>** | **<u>[FINANCIAL INFORMATION](#ie7d2cf4f294a4c48b9da5fb075e0f93b_10)</u>** | **PAGE** |
|  | **<u>[Item 1](#ie7d2cf4f294a4c48b9da5fb075e0f93b_13)</u>** | [Financial Statements (Unaudited):](#ie7d2cf4f294a4c48b9da5fb075e0f93b_13) |  |
|  |  | <u>[Consolidated Condensed Statements of Earnings](#ie7d2cf4f294a4c48b9da5fb075e0f93b_16)</u> | <u>[4](#ie7d2cf4f294a4c48b9da5fb075e0f93b_16)</u> |
|  |  | <u>[Consolidated Condensed Statements of Comprehensive Income](#ie7d2cf4f294a4c48b9da5fb075e0f93b_19)</u> | <u>[5](#ie7d2cf4f294a4c48b9da5fb075e0f93b_19)</u> |
|  |  | <u>[Consolidated Condensed Balance Sheets](#ie7d2cf4f294a4c48b9da5fb075e0f93b_22)</u> | <u>[6](#ie7d2cf4f294a4c48b9da5fb075e0f93b_22)</u> |
|  |  | <u>[Consolidated Condensed Statements of Shareholders' Equity](#ie7d2cf4f294a4c48b9da5fb075e0f93b_25)</u> | <u>[7](#ie7d2cf4f294a4c48b9da5fb075e0f93b_25)</u> |
|  |  | <u>[Consolidated Condensed Statements of Cash Flows](#ie7d2cf4f294a4c48b9da5fb075e0f93b_31)</u> | <u>[9](#ie7d2cf4f294a4c48b9da5fb075e0f93b_31)</u> |
|  |  | <u>[Notes to Consolidated Condensed Financial Statements](#ie7d2cf4f294a4c48b9da5fb075e0f93b_37)</u> | <u>[10](#ie7d2cf4f294a4c48b9da5fb075e0f93b_34)</u> |
|  | **<u>[Item 2](#ie7d2cf4f294a4c48b9da5fb075e0f93b_121)</u>** | <u>[Management's Discussion and Analysis of Financial Condition and Results of Operations](#ie7d2cf4f294a4c48b9da5fb075e0f93b_121)</u> | <u>[31](#ie7d2cf4f294a4c48b9da5fb075e0f93b_121)</u> |
|  | **<u>[Item 3](#ie7d2cf4f294a4c48b9da5fb075e0f93b_154)</u>** | <u>[Quantitative and Qualitative Disclosures about Market Risk](#ie7d2cf4f294a4c48b9da5fb075e0f93b_154)</u> | <u>[40](#ie7d2cf4f294a4c48b9da5fb075e0f93b_154)</u> |
|  | **<u>[Item 4](#ie7d2cf4f294a4c48b9da5fb075e0f93b_157)</u>** | <u>[Controls and Procedures](#ie7d2cf4f294a4c48b9da5fb075e0f93b_157)</u> | <u>[40](#ie7d2cf4f294a4c48b9da5fb075e0f93b_157)</u> |
| **<u>[PART II](#ie7d2cf4f294a4c48b9da5fb075e0f93b_160)</u>** | **<u>[OTHER INFORMATION](#ie7d2cf4f294a4c48b9da5fb075e0f93b_160)</u>** | **<u>[OTHER INFORMATION](#ie7d2cf4f294a4c48b9da5fb075e0f93b_160)</u>** |  |
|  | **<u>[Item 1A](#ie7d2cf4f294a4c48b9da5fb075e0f93b_163)</u>** | <u>[Risk Factors](#ie7d2cf4f294a4c48b9da5fb075e0f93b_163)</u> | <u>[41](#ie7d2cf4f294a4c48b9da5fb075e0f93b_163)</u> |
|  | **<u>[Item 2](#ie7d2cf4f294a4c48b9da5fb075e0f93b_166)</u>** | <u>[Unregistered Sales of Equity Securities and Use of Proceeds](#ie7d2cf4f294a4c48b9da5fb075e0f93b_166)</u> | <u>[42](#ie7d2cf4f294a4c48b9da5fb075e0f93b_166)</u> |
|  | **<u>[Item 6](#ie7d2cf4f294a4c48b9da5fb075e0f93b_169)</u>** | <u>[Exhibits](#ie7d2cf4f294a4c48b9da5fb075e0f93b_169)</u> | <u>[43](#ie7d2cf4f294a4c48b9da5fb075e0f93b_169)</u> |
| **<u>[SIGNATURES](#ie7d2cf4f294a4c48b9da5fb075e0f93b_172)</u>** | **<u>[SIGNATURES](#ie7d2cf4f294a4c48b9da5fb075e0f93b_172)</u>** | **<u>[SIGNATURES](#ie7d2cf4f294a4c48b9da5fb075e0f93b_172)</u>** | <u>[44](#ie7d2cf4f294a4c48b9da5fb075e0f93b_172)</u> |

---

------

<u>[**Table of Contents**](#ie7d2cf4f294a4c48b9da5fb075e0f93b_7)</u>

**PART I FINANCIAL INFORMATION**

**Item 1. Financial Statements**

![moogimage2a16.jpg](mog-20250628_g1.jpg)

**Consolidated Condensed Statements of Earnings**

(Unaudited)

---

| | | | | |
|:---|:---|:---|:---|:---|
| | Three Months Ended | Three Months Ended | Nine Months Ended | Nine Months Ended |
| (dollars in thousands, except share and per share data) | June 28,<br>2025 | June 29,<br>2024 | June 28,<br>2025 | June 29,<br>2024 |
| Net sales | $971363 | $904735 | $2816518 | $2691888 |
| Cost of sales | 699685 | 651672 | 2044373 | 1938673 |
| Inventory write-down | 5839 | 1600 | 7988 | 1775 |
| Gross profit | 265839 | 251463 | 764157 | 751440 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Research and development | 21906 | 27791 | 69992 | 86752 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Selling, general and administrative | 138801 | 126361 | 399684 | 370047 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Interest | 17790 | 18153 | 54340 | 52850 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Asset impairment | 3000 | 112 | 3000 | 6862 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Restructuring | 2850 | 3984 | 9059 | 12623 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other | 3510 | 4157 | 7942 | 10041 |
| Earnings before income taxes | 77982 | 70905 | 220140 | 212265 |
| Income taxes | 18275 | 14545 | 51566 | 48090 |
| Net earnings | $59707 | $56360 | $168574 | $164175 |
| Net earnings per share |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Basic | $1.89 | $1.76 | $5.32 | $5.14 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Diluted | $1.87 | $1.74 | $5.25 | $5.08 |
| Weighted average common shares outstanding |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Basic | 31524999 | 31960165 | 31684945 | 31943365 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Diluted | 31896949 | 32409370 | 32082186 | 32342700 |
| See accompanying Notes to Consolidated Condensed Financial Statements. | See accompanying Notes to Consolidated Condensed Financial Statements. | See accompanying Notes to Consolidated Condensed Financial Statements. | See accompanying Notes to Consolidated Condensed Financial Statements. | See accompanying Notes to Consolidated Condensed Financial Statements. |

---

------

<u>[**Table of Contents**](#ie7d2cf4f294a4c48b9da5fb075e0f93b_7)</u>

![Image2.jpg](mog-20250628_g1.jpg)

**Consolidated Condensed Statements of Comprehensive Income**

(Unaudited)

---

| | | | | |
|:---|:---|:---|:---|:---|
| | Three Months Ended | Three Months Ended | Nine Months Ended | Nine Months Ended |
| (dollars in thousands) | June 28,<br>2025 | June 29,<br>2024 | June 28,<br>2025 | June 29,<br>2024 |
| Net earnings | $59707 | $56360 | $168574 | $164175 |
| Other comprehensive income (loss) ("OCI"), net of tax: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Foreign currency translation adjustment | 53380 | (6650) | 34672 | 10637 |
| &nbsp;&nbsp;&nbsp;&nbsp;Retirement liability adjustment | 1112 | 2059 | 5928 | 5910 |
| &nbsp;&nbsp;&nbsp;&nbsp;Change in accumulated gain (loss) on derivatives | 504 |  | 1166 | 518 |
| Other comprehensive income (loss), net of tax | 54996 | (4591) | 41766 | 17065 |
| Comprehensive income | $114703 | $51769 | $210340 | $181240 |
| See accompanying Notes to Consolidated Condensed Financial Statements. | See accompanying Notes to Consolidated Condensed Financial Statements. | See accompanying Notes to Consolidated Condensed Financial Statements. | See accompanying Notes to Consolidated Condensed Financial Statements. | See accompanying Notes to Consolidated Condensed Financial Statements. |

---

------

<u>[**Table of Contents**](#ie7d2cf4f294a4c48b9da5fb075e0f93b_7)</u>

![Image3.jpg](mog-20250628_g1.jpg)

**Consolidated Condensed Balance Sheets**

(Unaudited)

---

| | | |
|:---|:---|:---|
| (dollars in thousands) | June 28,<br>2025 | September 28,<br>2024 |
| **ASSETS** |  |  |
| Current assets |  |  |
| &nbsp;&nbsp;&nbsp;Cash and cash equivalents | $58191 | $61694 |
| &nbsp;&nbsp;&nbsp;Restricted cash | 823 | 123 |
| &nbsp;&nbsp;&nbsp;Receivables, net | 529753 | 419971 |
| &nbsp;&nbsp;Unbilled receivables | 734976 | 709014 |
| &nbsp;&nbsp;&nbsp;Inventories, net | 924682 | 863702 |
| &nbsp;&nbsp;&nbsp;Prepaid expenses and other current assets | 153479 | 86245 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total current assets | 2401904 | 2140749 |
| Property, plant and equipment, net | 988125 | 929357 |
| Operating lease right-of-use assets | 52877 | 52591 |
| Goodwill | 802089 | 833764 |
| Intangible assets, net | 57182 | 63479 |
| Deferred income taxes | 37701 | 20991 |
| Other assets | 56696 | 52695 |
| Total assets | $4396574 | $4093626 |
| **LIABILITIES AND SHAREHOLDERS' EQUITY** |  |  |
| Current liabilities |  |  |
| &nbsp;&nbsp;&nbsp;Accounts payable | $289160 | $292988 |
| &nbsp;&nbsp;&nbsp;Accrued compensation | 98292 | 101127 |
| &nbsp;&nbsp;&nbsp;Contract advances and progress billings | 298648 | 299732 |
| &nbsp;&nbsp;&nbsp;Accrued liabilities and other | 302514 | 305180 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total current liabilities | 988614 | 999027 |
| Long-term debt, excluding current installments | 1081674 | 874139 |
| Long-term pension and retirement obligations | 177688 | 167161 |
| Deferred income taxes | 27664 | 27738 |
| Other long-term liabilities | 177233 | 164928 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total liabilities | 2452873 | 2232993 |
| Shareholders' equity |  |  |
| &nbsp;&nbsp;&nbsp;Common stock - Class A | 43864 | 43835 |
| &nbsp;&nbsp;&nbsp;Common stock - Class B | 7416 | 7445 |
| &nbsp;&nbsp;&nbsp;Additional paid-in capital | 769935 | 784509 |
| &nbsp;&nbsp;&nbsp;Retained earnings | 2810050 | 2668723 |
| &nbsp;&nbsp;&nbsp;Treasury shares | (1205305) | (1082240) |
| &nbsp;&nbsp;&nbsp;Stock Employee Compensation Trust | (173214) | (194049) |
| &nbsp;&nbsp;&nbsp;Supplemental Retirement Plan Trust | (147042) | (163821) |
| &nbsp;&nbsp;&nbsp;Accumulated other comprehensive loss | (162003) | (203769) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total shareholders' equity | 1943701 | 1860633 |
| Total liabilities and shareholders' equity | $4396574 | $4093626 |
| See accompanying Notes to Consolidated Condensed Financial Statements. |  |  |

---

------

<u>[**Table of Contents**](#ie7d2cf4f294a4c48b9da5fb075e0f93b_7)</u>

![Image4.jpg](mog-20250628_g1.jpg)

**Consolidated Condensed Statements of Shareholders' Equity**

(Unaudited)

---

| | | | | |
|:---|:---|:---|:---|:---|
| | Three Months Ended | Three Months Ended | Nine Months Ended | Nine Months Ended |
| (dollars in thousands) | June 28,<br>2025 | June 29,<br>2024 | June 28,<br>2025 | June 29,<br>2024 |
| COMMON STOCK |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Beginning and end of period | $51280 | $51280 | $51280 | $51280 |
| ADDITIONAL PAID-IN CAPITAL |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Beginning of period | 750119 | 702272 | 784509 | 608270 |
| &nbsp;&nbsp;&nbsp;Issuance of treasury shares | 3035 | (127) | 11585 | 6159 |
| &nbsp;&nbsp;&nbsp;Equity-based compensation expense | 3659 | 3316 | 9673 | 8952 |
| &nbsp;&nbsp;&nbsp;Adjustment to market - SECT and SERP | 13122 | 21195 | (35832) | 103275 |
| &nbsp;&nbsp;&nbsp;End of period | 769935 | 726656 | 769935 | 726656 |
| RETAINED EARNINGS |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Beginning of period | 2759484 | 2587222 | 2668723 | 2496979 |
| &nbsp;&nbsp;&nbsp;Net earnings | 59707 | 56360 | 168574 | 164175 |
| &nbsp;&nbsp;Dividends <sup>(1)</sup>  | (9141) | (8949) | (27247) | (26521) |
| &nbsp;&nbsp;&nbsp;End of period | 2810050 | 2634633 | 2810050 | 2634633 |
| TREASURY SHARES AT COST |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Beginning of period | (1204032) | (1071558) | (1082240) | (1057938) |
| &nbsp;&nbsp;&nbsp;Class A and B shares issued related to compensation | 110 | 125 | 5673 | 6743 |
| &nbsp;&nbsp;Class A and B shares purchased | (1383) | (1594) | (128738) | (21832) |
| &nbsp;&nbsp;&nbsp;End of period | (1205305) | (1073027) | (1205305) | (1073027) |
| STOCK EMPLOYEE COMPENSATION TRUST ("SECT") |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Beginning of period | (162945) | (153295) | (194049) | (114769) |
| &nbsp;&nbsp;&nbsp;Issuance of shares | 998 | 882 | 20287 | 16670 |
| &nbsp;&nbsp;&nbsp;Purchase of shares | (3697) | (4889) | (18505) | (13706) |
| &nbsp;&nbsp;&nbsp;Adjustment to market | (7570) | (10455) | 19053 | (55952) |
| &nbsp;&nbsp;&nbsp;End of period | (173214) | (167757) | (173214) | (167757) |
| SUPPLEMENTAL RETIREMENT PLAN ("SERP") TRUST |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Beginning of period | (141490) | (129709) | (163821) | (93126) |
| &nbsp;&nbsp;&nbsp;Adjustment to market | (5552) | (10740) | 16779 | (47323) |
| &nbsp;&nbsp;&nbsp;End of period | (147042) | (140449) | (147042) | (140449) |
| ACCUMULATED OTHER COMPREHENSIVE LOSS |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Beginning of period | (216999) | (232953) | (203769) | (254609) |
| &nbsp;&nbsp;&nbsp;Other comprehensive income (loss) | 54996 | (4591) | 41766 | 17065 |
| &nbsp;&nbsp;&nbsp;End of period | (162003) | (237544) | (162003) | (237544) |
| TOTAL SHAREHOLDERS' EQUITY | $1943701 | $1793792 | $1943701 | $1793792 |
| See accompanying Notes to Consolidated Condensed Financial Statements. | See accompanying Notes to Consolidated Condensed Financial Statements. | See accompanying Notes to Consolidated Condensed Financial Statements. | See accompanying Notes to Consolidated Condensed Financial Statements. | See accompanying Notes to Consolidated Condensed Financial Statements. |

---

<sup>(1)</sup> Cash dividends were $0.29 and $0.86 per share for the three and nine months ended June 28, 2025 and $0.28 and $0.83 per share for the three and nine months ended June 29, 2024, respectively.

------

<u>[**Table of Contents**](#ie7d2cf4f294a4c48b9da5fb075e0f93b_7)</u>

![Image5.jpg](mog-20250628_g1.jpg)

**Consolidated Condensed Statements of Shareholders' Equity, Shares**

(Unaudited)

---

| | | | | |
|:---|:---|:---|:---|:---|
| | Three Months Ended | Three Months Ended | Nine Months Ended | Nine Months Ended |
| (share data) | June 28,<br>2025 | June 29,<br>2024 | June 28,<br>2025 | June 29,<br>2024 |
| COMMON STOCK - CLASS A |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Beginning of period | 43850739 | 43826350 | 43835149 | 43822344 |
| &nbsp;&nbsp;&nbsp;Conversion of Class B to Class A | 12659 | 8122 | 28249 | 12128 |
| &nbsp;&nbsp;&nbsp;End of period | 43863398 | 43834472 | 43863398 | 43834472 |
| COMMON STOCK - CLASS B |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Beginning of period | 7428974 | 7453363 | 7444564 | 7457369 |
| &nbsp;&nbsp;&nbsp;Conversion of Class B to Class A | (12659) | (8122) | (28249) | (12128) |
| &nbsp;&nbsp;&nbsp;End of period | 7416315 | 7445241 | 7416315 | 7445241 |
| TREASURY SHARES - CLASS A COMMON STOCK |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Beginning of period | (15136065) | (14645847) | (14633512) | (14657897) |
| &nbsp;&nbsp;&nbsp;Class A shares issued related to compensation |  | 2285 | 12758 | 22670 |
| &nbsp;&nbsp;&nbsp;Class A shares purchased |  | (993) | (515311) | (9328) |
| &nbsp;&nbsp;&nbsp;End of period | (15136065) | (14644555) | (15136065) | (14644555) |
| TREASURY SHARES - CLASS B COMMON STOCK |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Beginning of period | (2843246) | (2865801) | (2861088) | (2896845) |
| &nbsp;&nbsp;&nbsp;Class B shares issued related to compensation | 25156 | 8688 | 169914 | 177153 |
| &nbsp;&nbsp;&nbsp;Class B shares purchased | (7899) | (8688) | (134815) | (146109) |
| &nbsp;&nbsp;&nbsp;End of period | (2825989) | (2865801) | (2825989) | (2865801) |
| SECT - CLASS A COMMON STOCK |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Beginning and end of period | (425148) | (425148) | (425148) | (425148) |
| SECT - CLASS B COMMON STOCK |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Beginning of period | (525084) | (544075) | (548084) | (592128) |
| &nbsp;&nbsp;&nbsp;Issuance of shares | 5617 | 5325 | 101649 | 116770 |
| &nbsp;&nbsp;&nbsp;Purchase of shares | (21464) | (29662) | (94496) | (93054) |
| &nbsp;&nbsp;&nbsp;End of period | (540931) | (568412) | (540931) | (568412) |
| SERP - CLASS B COMMON STOCK |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Beginning and end of period | (826170) | (826170) | (826170) | (826170) |
| See accompanying Notes to Consolidated Condensed Financial Statements. | See accompanying Notes to Consolidated Condensed Financial Statements. | See accompanying Notes to Consolidated Condensed Financial Statements. | See accompanying Notes to Consolidated Condensed Financial Statements. | See accompanying Notes to Consolidated Condensed Financial Statements. |

---

------

<u>[**Table of Contents**](#ie7d2cf4f294a4c48b9da5fb075e0f93b_7)</u>

![Image6.jpg](mog-20250628_g1.jpg)

**Consolidated Condensed Statements of Cash Flows**

(Unaudited)

---

| | | |
|:---|:---|:---|
| | Nine Months Ended | Nine Months Ended |
| (dollars in thousands) | June 28,<br>2025 | June 29,<br>2024 |
| CASH FLOWS FROM OPERATING ACTIVITIES |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net earnings | $168574 | $164175 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Adjustments to reconcile net earnings to net cash provided (used) by operating activities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Depreciation | 69292 | 64302 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Amortization | 6996 | 7677 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Deferred income taxes | (18645) | (26483) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Equity-based compensation expense | 12669 | 11301 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Asset impairment and inventory write-down | 10988 | 8637 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other | 4399 | 5374 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Changes in assets and liabilities providing (using) cash: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Receivables | (105346) | (18677) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Unbilled receivables | (35174) | (57723) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Inventories | (64095) | (105629) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts payable | (3301) | 918 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Contract advances and progress billings | 8798 | (26882) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accrued expenses | (6645) | 36928 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accrued income taxes | (22669) | 9832 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net pension and post retirement liabilities | 15563 | 8783 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other assets and liabilities | (8941) | (35978) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash provided (used) by operating activities | 32463 | 46555 |
| CASH FLOWS FROM INVESTING ACTIVITIES |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Acquisitions of businesses, net of cash acquired |  | (5911) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Purchase of property, plant and equipment | (103041) | (109616) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net proceeds from businesses sold | 13487 | 1627 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other investing transactions | (2844) | (646) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash provided (used) by investing activities | (92398) | (114546) |
| CASH FLOWS FROM FINANCING ACTIVITIES |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Proceeds from revolving lines of credit | 957500 | 784500 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Payments on revolving lines of credit | (1001500) | (691000) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Proceeds from long-term debt | 250000 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Payments on finance lease obligations | (7194) | (4468) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Payment of dividends | (27247) | (26521) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Proceeds from sale of treasury stock | 10970 | 7579 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Purchase of outstanding shares for treasury | (127808) | (21832) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Proceeds from sale of stock held by SECT | 20287 | 16670 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Purchase of stock held by SECT | (18505) | (14296) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other financing transactions | (1600) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash provided (used) by financing activities | 54903 | 50632 |
| Effect of exchange rate changes on cash | (491) | (267) |
| Increase (decrease) in cash, cash equivalents and restricted cash | (5523) | (17626) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cash, cash equivalents and restricted cash at beginning of period <sup>(1)</sup> | 64537 | 69144 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cash, cash equivalents and restricted cash at end of period | $59014 | $51518 |
| SUPPLEMENTAL CASH FLOW INFORMATION |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Treasury shares issued as compensation | $6288 | $5323 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Assets acquired through lease financing | 36787 | 27034 |
| See accompanying Notes to Consolidated Condensed Financial Statements. | See accompanying Notes to Consolidated Condensed Financial Statements. | See accompanying Notes to Consolidated Condensed Financial Statements. |

---

<sup>(1)</sup> Beginning of period cash balance at September 29, 2024 includes cash related to assets held for sale of $2,720.

------

<u>[**Table of Contents**](#ie7d2cf4f294a4c48b9da5fb075e0f93b_7)</u>

![Image7.jpg](mog-20250628_g1.jpg)

**Notes to Consolidated Condensed Financial Statements**

**Nine Months Ended June 28, 2025** 

**(Unaudited)**

**(dollars in thousands, except per share data)**

**Note 1 - Basis of Presentation**

The accompanying unaudited consolidated condensed financial statements have been prepared by management in accordance with U.S. generally accepted accounting principles for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. In the opinion of management, all adjustments consisting of normal recurring adjustments considered necessary for the fair presentation of results for the interim period have been included. The results of operations for the three and nine months ended June 28, 2025 are not necessarily indicative of the results expected for the full year. The accompanying unaudited consolidated condensed financial statements should be read in conjunction with the financial statements and notes thereto included in our Form 10-K for the fiscal year ended September 28, 2024. All references to years in these financial statements are to fiscal years.

<u>Recent Accounting Pronouncements Adopted</u>

There have been no new accounting pronouncements adopted for the nine months ended June 28, 2025.

<u>Recent Accounting Pronouncements Not Yet Adopted</u>

---

| | | |
|:---|:---|:---|
| Standard | Description | Financial Statement Effect or Other Significant Matters |
| ASU no. 2023-07<br>*Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures* | This standard requires disclosure of significant segment expenses that are regularly provided to the chief operating decision maker ("CODM") and included within each reported measure of segment profit or loss. The amendments also require disclosure of all other segment items by reportable segment and a description of its composition. Additionally, the amendments require disclosure of the title and position of the CODM and an explanation of how the CODM uses the reported measures of segment profit or loss in assessing segment performance and deciding how to allocate resources. The provisions of the standard are effective for fiscal years beginning after December 15, 2023 and interim periods within fiscal years beginning after December 15, 2024. Early adoption is permitted. The amendment requires retrospective application to all prior periods presented in the financial statements. | We are currently reviewing the guidance and evaluating the impact on our financial statements and related disclosures. |
| ASU no. 2023-07<br>*Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures* | This standard requires disclosure of significant segment expenses that are regularly provided to the chief operating decision maker ("CODM") and included within each reported measure of segment profit or loss. The amendments also require disclosure of all other segment items by reportable segment and a description of its composition. Additionally, the amendments require disclosure of the title and position of the CODM and an explanation of how the CODM uses the reported measures of segment profit or loss in assessing segment performance and deciding how to allocate resources. The provisions of the standard are effective for fiscal years beginning after December 15, 2023 and interim periods within fiscal years beginning after December 15, 2024. Early adoption is permitted. The amendment requires retrospective application to all prior periods presented in the financial statements. | Planned date of adoption: <br>FY 2025 |
| ASU no. 2023-09<br>*Income Taxes (Topic 740): Improvements to Income Tax Disclosures* | This standard expands annual income tax disclosures to require specific categories in the rate reconciliation table to be disclosed using both percentages and reporting currency amounts and requires additional information for reconciling items that meet a quantitative threshold. Additionally, the amendment requires disclosure of income taxes paid by jurisdiction. The provisions of the standard are effective for fiscal years beginning after December 15, 2024. Early adoption is permitted. The amendments should be applied on a prospective basis. Retrospective application is permitted. | We are currently reviewing the guidance and evaluating the impact on our financial statements and related disclosures. |
| ASU no. 2023-09<br>*Income Taxes (Topic 740): Improvements to Income Tax Disclosures* | This standard expands annual income tax disclosures to require specific categories in the rate reconciliation table to be disclosed using both percentages and reporting currency amounts and requires additional information for reconciling items that meet a quantitative threshold. Additionally, the amendment requires disclosure of income taxes paid by jurisdiction. The provisions of the standard are effective for fiscal years beginning after December 15, 2024. Early adoption is permitted. The amendments should be applied on a prospective basis. Retrospective application is permitted. | Planned date of adoption: <br>FY 2026 |
| ASU no. 2024-03<br>*Income Statement - Reporting Comprehensive Income-Expense Disaggregation Disclosures (Topic 220): Disaggregation of Income Statement Expenses* | This standard requires disclosure of specified information about certain cost and expenses at each interim and annual reporting period. This includes disclosure of the amounts of purchases of inventory, employee compensation, depreciation and intangible asset for each relevant expense caption on the income statement, as well as the total amount of selling expenses. Additionally, the amendments require disclosing a qualitative description of the amounts remaining in relevant expense captions that are not separately disaggregated. The provisions of the standard are effective for fiscal years beginning after December 15, 2026 and interim periods within fiscal years beginning after December 15, 2027. Early adoption is permitted. The amendments may be applied either prospectively to financial statements issued for reporting periods after the effective date of this ASU or retrospectively to all prior periods presented in the financial statements. | We are currently reviewing the guidance and evaluating the impact on our financial statements and related disclosures. |
| ASU no. 2024-03<br>*Income Statement - Reporting Comprehensive Income-Expense Disaggregation Disclosures (Topic 220): Disaggregation of Income Statement Expenses* | This standard requires disclosure of specified information about certain cost and expenses at each interim and annual reporting period. This includes disclosure of the amounts of purchases of inventory, employee compensation, depreciation and intangible asset for each relevant expense caption on the income statement, as well as the total amount of selling expenses. Additionally, the amendments require disclosing a qualitative description of the amounts remaining in relevant expense captions that are not separately disaggregated. The provisions of the standard are effective for fiscal years beginning after December 15, 2026 and interim periods within fiscal years beginning after December 15, 2027. Early adoption is permitted. The amendments may be applied either prospectively to financial statements issued for reporting periods after the effective date of this ASU or retrospectively to all prior periods presented in the financial statements. | Planned date of adoption: <br>FY 2028 |

---

We consider the applicability and impact of all Accounting Standard Updates ("ASU"). ASUs not listed above were assessed and determined to be either not applicable, or had or are expected to have an immaterial impact on our financial statements and related disclosures.

------

<u>[**Table of Contents**](#ie7d2cf4f294a4c48b9da5fb075e0f93b_7)</u>

<u>Out of Period Adjustment</u>

In the first quarter of 2025, the Company recorded an out of period adjustment to correct an error identified by management related to its warranty expense in Commercial Aircraft. The adjustment resulted in an increase to cost of sales and a decrease to unbilled receivables of $7,540. The Company has evaluated the impacts of this error, both quantitatively and qualitatively, and has concluded the error was not material to any prior interim or annual period. The correction is not expected to be material to the year ending September 27, 2025.

**Note 2 - Revenue from Contracts with Customers**

We recognize revenue from contracts with customers using the five-step model prescribed in ASC 606. The first step is identifying the contract. The identification of a contract with a customer requires an assessment of each party's rights and obligations regarding the products or services to be transferred, including an evaluation of termination clauses and presently enforceable rights and obligations. Each party's rights and obligations and the associated terms and conditions are typically determined in purchase orders. For sales that are governed by master supply agreements under which provisions define specific program requirements, purchase orders are issued under these agreements to reflect presently enforceable rights and obligations for the units of products and services being purchased.

Contracts are sometimes modified to account for changes in contract specifications and requirements. When this occurs, we assess the modification as prescribed in ASC 606 and determine whether the existing contract needs to be modified (and revenue cumulatively caught up), whether the existing contract needs to be terminated and a new contract needs to be created, or whether the existing contract remains and a new contract needs to be created. This is determined based on the rights and obligations within the modification as well as the associated transaction price.

The next step is identifying the performance obligations. A performance obligation is a promise to transfer goods or services to a customer that is distinct in the context of the contract, as defined by ASC 606. We identify a performance obligation for each promise in a contract to transfer a distinct good or service to the customer. As part of our assessment, we consider all goods and/or services promised in the contract, regardless of whether they are explicitly stated or implied by customary business practices. The products and services in our contracts are typically not distinct from one another due to their complexity and reliance on each other or, in many cases, we provide a significant integration service. Accordingly, many of our contracts are accounted for as one performance obligation. In limited cases, our contracts have more than one distinct performance obligation, which occurs when we perform activities that are not highly complex or interrelated or involve different product life cycles. Warranties are provided on certain contracts, but do not typically provide for services beyond standard assurances and are therefore not distinct performance obligations under ASC 606.

The third step is determining the transaction price, which represents the amount of consideration we expect to be entitled to receive from a customer in exchange for providing the goods or services. There are times when this consideration is variable, for example a volume discount, and must be estimated. Sales, use, value-added, and excise taxes are excluded from the transaction price, where applicable.

The fourth step is allocating the transaction price. The transaction price must be allocated to the performance obligations identified in the contract based on relative stand-alone selling prices when available, or an estimate for each distinct good or service in the contract when standalone prices are not available. Our contracts with customers generally require payment under normal commercial terms after delivery. Payment terms are typically within 30 to 60 days of delivery. The timing of satisfaction of our performance obligations does not significantly vary from the typical timing of payment.

The final step is the recognition of revenue. We recognize revenue as the performance obligations are satisfied. ASC 606 provides guidance to help determine if we are satisfying the performance obligation at a point in time or over time. In determining when performance obligations are satisfied, we consider factors such as contract terms, payment terms and whether there is an alternative use of the product or service. In essence, we recognize revenue when, or as control of, the promised goods or services transfer to the customer.

------

<u>[**Table of Contents**](#ie7d2cf4f294a4c48b9da5fb075e0f93b_7)</u>

Revenue is recognized using either the over time or point in time method. The over-time method of revenue recognition is predominantly used in Space and Defense, Military Aircraft and Commercial Aircraft. We use this method for U.S. Government contracts and repair and overhaul arrangements as we are creating or enhancing assets that the customer controls as the assets are being created or enhanced. In addition, many of our large commercial contracts qualify for over-time accounting as our performance does not create an asset with an alternative use and we have an enforceable right to payment for performance completed to date. Our over-time contracts are primarily firm fixed price.

Revenue recognized at the point in time control is transferred to the customer is used most frequently in Industrial. We use this method for commercial contracts in which the asset being created has an alternative use. We determine the point in time control transfers to the customer by weighing the five indicators provided by ASC 606 - the entity has a present right to payment; the customer has legal title; the customer has physical possession; the customer has significant risks and rewards of ownership; and the customer has accepted the asset. When control has transferred to the customer, profit is generated as cost of sales is recorded and as revenue is recognized. Inventory costs include all product manufacturing costs such as direct material, direct labor, other direct costs and indirect overhead cost allocations. Shipping and handling costs are considered costs to fulfill a contract and not considered performance obligations. They are included in cost of sales as incurred.

Revenue is recognized over time on contracts using the cost-to-cost method of accounting as work progresses toward completion as determined by the ratio of cumulative costs incurred to date to estimated total contract costs at completion, multiplied by the total estimated contract revenue, less cumulative revenue recognized in prior periods. We believe that cumulative costs incurred to date as a percentage of estimated total contract costs at completion is an appropriate measure of progress toward satisfaction of performance obligations as this measure most accurately depicts the progress of our work and transfer of control to our customers. Changes in estimates affecting sales, costs and profits are recognized in the period in which the change becomes known using the cumulative catch-up method of accounting, resulting in the cumulative effect of changes reflected in the period. Estimates are reviewed and updated quarterly for substantially all contracts. For the three and nine months ended June 28, 2025 we recognized additional revenue of $4,204 and $15,478, for adjustments made to performance obligations satisfied (or partially satisfied) in previous periods. For the three and nine months ended June 29, 2024 we recognized lower revenue of $10,565 and $8,181 respectively, for adjustments made to performance obligations satisfied (or partially satisfied) in previous periods.

Contract costs include only allocable, allowable and reasonable costs which are included in cost of sales when incurred. For applicable U.S. Government contracts, contract costs are determined in accordance with the Federal Acquisition Regulations and the related Cost Accounting Standards. The nature of these costs includes development engineering costs and product manufacturing costs such as direct material, direct labor, other direct costs and indirect overhead costs. Contract profit is recorded as a result of the revenue recognized less costs incurred in any reporting period. Variable consideration and contract modifications, such as performance incentives, penalties, contract claims or change orders are considered in estimating revenues, costs and profits when they can be reliably estimated and realization is considered probable. Revenue recognized on contracts for unresolved claims or unapproved contract change orders was not material for the three and nine months ended June 28, 2025.

As of June 28, 2025, we had contract reserves of $69,832. For contracts with anticipated losses at completion, a provision for the entire amount of the estimated remaining loss is charged against income in the period in which the loss becomes known. Contract losses are determined considering all direct and indirect contract costs, exclusive of any selling, general or administrative cost allocations that are treated as period expenses. Loss reserves are more common on firm fixed-price contracts that involve, to varying degrees, the design and development of new and unique controls or control systems to meet the customers' specifications. We calculate contract losses at the contract level, versus the performance obligation level. Recall reserves are recorded when additional work is needed on completed products for them to meet contract specifications. Contract-related loss reserves are recorded for the additional work needed on completed and delivered products in order for them to meet contract specifications.

<u>Contract Assets and Liabilities</u>

Unbilled receivables (contract assets) primarily represent revenues recognized for performance obligations that have been satisfied but for which amounts have not been billed. Unbilled receivables are classified as current assets and in accordance with industry practice, include amounts that may be billed and collected beyond one year due to the long term nature of our contracts.

------

<u>[**Table of Contents**](#ie7d2cf4f294a4c48b9da5fb075e0f93b_7)</u>

Contract advances and progress billings (contract liabilities) relate to payments received from customers in advance of the satisfaction of performance obligations for a contract (contract advances) and when billings are in excess of revenue recognized (progress billings). These amounts are recorded as contract liabilities until such obligations are satisfied, either over-time as costs are incurred or at a point when deliveries are made. We do not consider contract advances and progress billings to be significant financing components as the intent of these payments in advance are for reasons other than providing a significant financing benefit and are customary in our industry.

For contracts recognized using the cost-to-cost method, the amount of unbilled receivables or contract advances and progress billings is determined for each contract to determine the contract asset or contract liability position at the end of each reporting period.

Total contract assets and contract liabilities are as follows:

---

| | | |
|:---|:---|:---|
| | June 28,<br>2025 | September 28, 2024 |
| Unbilled receivables | $734976 | $709014 |
| Contract advances and progress billings | 298648 | 299732 |
| Net contract assets | $436328 | $409282 |

---

The increase in net contract assets primarily reflects the impact of additional unbilled revenues during the period. For the three and nine months ended June 28, 2025, we recognized $51,410 and $214,106 of revenue, that was included in the contract liability balance at the beginning of the year.

<u>Remaining Performance Obligations</u>

As of June 28, 2025, the aggregate amount of the transaction price allocated to the performance obligations that are unsatisfied (or partially unsatisfied) was $5,510,000. We expect to recognize approximately 48% of that amount as sales over the next twelve months and the balance thereafter.

<u>Disaggregation of Revenue</u>

See Note 20 - Segments, for disclosures related to disaggregation of revenue.

**Note 3 - Acquisitions, Divestitures and Assets Held for Sale**

<u>Acquisitions</u>

On October 20, 2023, we acquired Data Collection Limited ("DCL") based in Auckland, New Zealand for a purchase price, net of acquired cash, of $5,911. DCL specializes in manufacturing and operating pavement surveying equipment and providing innovative solutions for measuring and managing pavements. This operation is included in our Military Aircraft segment. The sales and results of operations of DCL are immaterial in 2025 and 2024.

On July 1, 2025, we acquired COTSWORKS, Inc., based in Ohio for a purchase price, net of cash acquired, of $63,000, which was paid in cash and the issuance of Moog Class A shares valued at $21,940. COTSWORKS designs and manufactures rugged optical components and subsystems for harsh environment applications, primarily serving the commercial, military, aerospace and industrial markets. It will be included in our Space and Defense segment.

<u>Divestitures</u>

In the fourth quarter of 2024, we recorded losses in Asset impairment and fair value adjustment of $14,897, related to selling a motors business in the Czech Republic and a hydraulic systems business in Luxembourg that were included in our Industrial segment. As a result, we have classified $9,360 in prepaid expenses and other current assets and $5,153 in accrued liabilities and other as held for sale at September 28, 2024. We completed the sale of these businesses on September 30, 2024, which required the release of the associated cumulative translation adjustment. There has been no significant change to the losses recognized as a result of completing the transactions.

------

<u>[**Table of Contents**](#ie7d2cf4f294a4c48b9da5fb075e0f93b_7)</u>

<u>Assets Held for Sale</u>

In the third quarter of 2025, we have classified a non-core business within our Space and Defense segment as held for sale. We have classified $53,787 in prepaid expenses and other current assets and $17,856 in accrued liabilities and other as held for sale. See Note 8 - Goodwill and Intangible Assets for additional details.

**Note 4 - Receivables**

Receivables consist of:

---

| | | |
|:---|:---|:---|
| | June 28,<br>2025 | September 28,<br>2024 |
| Accounts receivable | $493848 | $388841 |
| Government assistance receivables | 10659 | 16673 |
| Other | 32149 | 17530 |
| Less allowance for credit losses | (6903) | (3073) |
| Receivables, net | $529753 | $419971 |

---

Moog Receivables LLC (the "Receivables Subsidiary"), a wholly owned bankruptcy remote special purpose subsidiary of Moog Inc. (the "Company"), as seller, the Company, as master servicer, Wells Fargo Bank, N.A., as administrative agent (the "Agent") and certain purchasers (collectively, the "Purchasers") entered into an Amended and Restated Receivables Purchase Agreement (the "RPA"). The RPA matures on December 11, 2026 and is subject to customary termination events related to transactions of this type.

Under the RPA, the Receivables Subsidiary may sell receivables to the Purchasers in amounts up to a $125,000 limit. The receivables will be sold to the Purchasers in consideration for the Purchasers making payments of cash, which is referred to as "capital" for purposes of the RPA, to the Receivables Subsidiary in accordance with the terms of the RPA. The Receivables Subsidiary may sell receivables to the Purchasers so long as certain conditions are satisfied, including that, at any date of determination, the aggregate capital paid to the Receivables Subsidiary does not exceed a "capital coverage amount," equal to an adjusted net receivables pool balance minus a required reserve. Each Purchaser's share of capital accrues yield at a variable rate plus an applicable margin.

The parties intend that the conveyance of receivables to the Agent, for the ratable benefit of the Purchasers will constitute a purchase and sale of receivables and not a pledge for security. The Receivables Subsidiary has guaranteed to each Purchaser and Agent the prompt payment of sold receivables, and to secure the prompt payment and performance of such guaranteed obligations, the Receivables Subsidiary has granted a security interest to the Agent, for the benefit of the Purchasers, in all assets of the Receivables Subsidiary. The assets of the Receivables Subsidiary are not available to pay our creditors or any affiliate thereof. In our capacity as master servicer under the RPA, we are responsible for administering and collecting receivables and have made customary representations, warranties, covenants and indemnities.

The proceeds of the RPA are classified as operating activities in our Consolidated Condensed Statements of Cash Flows. Cash received from collections of sold receivables is used by the Receivables Subsidiary to fund additional purchases of receivables on a revolving basis or to return all or any portion of outstanding capital of the Purchaser. Subsequent collections on the pledged receivables, which have not been sold, will be classified as operating cash flows at the time of collection. Total receivables sold and cash collections under the RPA were $144,670 and $498,111 for the three and nine months ended June 28, 2025, respectively. The fair value of the sold receivables approximated book value due to their credit quality and short-term nature, and as a result, no gain or loss on sale of receivables was recorded.

As of June 28, 2025, the amount sold to the Purchasers was $125,000, which was derecognized from the Consolidated Condensed Balance Sheets. As collateral against sold receivables, the Receivables Subsidiary maintains a certain level of unsold receivables, which was $633,881 at June 28, 2025.

The allowance for credit losses is based on our assessment of the collectability of customer accounts. The allowance is determined by considering factors such as historical experience, credit quality, age of the accounts receivable, current economic conditions and reasonable forecasted financial information that may affect a customer's ability to pay.

------

**Note 5 - Inventories**

Inventories, net of reserves, consist of:

---

| | | |
|:---|:---|:---|
| | June 28,<br>2025 | September 28,<br>2024 |
| Raw materials and purchased parts | $311860 | $291969 |
| Work in progress | 517865 | 489503 |
| Finished goods | 94957 | 82230 |
| Inventories, net | $924682 | $863702 |

---

There are no material inventoried costs relating to over-time contracts where revenue is accounted for using the cost-to-cost method of accounting as of June 28, 2025 and September 28, 2024.

**Note 6 - Property, Plant and Equipment**

Property, plant and equipment consists of:

---

| | | |
|:---|:---|:---|
| | June 28,<br>2025 | September 28,<br>2024 |
| Land | $34044 | $32270 |
| Buildings and improvements | 732508 | 698333 |
| Machinery and equipment | 949939 | 900187 |
| Computer equipment and software | 248485 | 237604 |
| Property, plant and equipment, at cost | 1964976 | 1868394 |
| Less accumulated depreciation and amortization | (976851) | (939037) |
| Property, plant and equipment, net | $988125 | $929357 |

---

------

**Note 7 - Leases**

We lease certain manufacturing facilities, office space and machinery and equipment globally. At inception, we evaluate whether a contractual arrangement contains a lease. Specifically, we consider whether we control the underlying asset and have the right to obtain substantially all the economic benefits or outputs from the asset. If the contractual arrangement contains a lease, we then determine the classification of the lease, operating or finance, using the classification criteria described in ASC 842. We then determine the term of the lease based on terms and conditions of the contractual arrangement, including whether the options to extend or terminate the lease are reasonably certain to be exercised. We have elected to not separate lease components from non-lease components, such as common area maintenance charges and instead, account for the lease and non-lease components as a single component.

Our lease right-of-use ("ROU") assets represent our right to use an underlying asset for the lease term and our lease liabilities represent our obligation to make lease payments. The ROU assets and lease liabilities for both operating and finance leases are recognized as of the commencement date at the net present value of the fixed minimum lease payments over the term of the lease including expected buyouts, using the discount rate described below. Variable lease payments are recorded in the period in which the obligation for the payment is incurred. Variable lease payments based on an index or rate are initially measured using the index or rate as of the commencement date of the lease and included in the fixed minimum lease payments. For short-term leases that have a term of 12 months or less as of the commencement date, we do not recognize a ROU asset or lease liability on our balance sheet; we recognize expense as the lease payments are made over the lease term.

Operating lease cost is included in Cost of sales and Selling, general and administrative on the Consolidated Condensed Statements of Earnings. Finance lease cost is included in Cost of sales, Selling, general and administrative and Interest on the Consolidated Condensed Statements of Earnings.

The discount rate used to calculate the present value of our leases is the rate implicit in the lease. If the information necessary to determine the rate implicit in the lease is not available, we use our incremental borrowing rate for collateralized debt, which is determined using our credit rating and other information available as of the lease commencement date.

The components of lease expense were as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | Three Months Ended | Three Months Ended | Nine Months Ended | Nine Months Ended |
| | June 28,<br>2025 | June 29,<br>2024 | June 28,<br>2025 | June 29,<br>2024 |
| Operating lease cost | $8261 | $7897 | $24518 | $23112 |
| Finance lease cost: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Amortization of right-of-use assets | $2792 | $2365 | $8871 | $6263 |
| &nbsp;&nbsp;&nbsp;Interest on lease liabilities | 1980 | 1421 | 6266 | 3988 |
| Total finance lease cost | $4772 | $3786 | $15137 | $10251 |

---

Supplemental cash flow information related to leases was as follows:

---

| | | |
|:---|:---|:---|
| | Nine Months Ended | Nine Months Ended |
| | June 28,<br>2025 | June 29,<br>2024 |
| Cash paid for amounts included in the measurement of lease liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;Operating cash flow for operating leases | $24958 | $23631 |
| &nbsp;&nbsp;&nbsp;Operating cash flow for finance leases | 6266 | 3988 |
| &nbsp;&nbsp;&nbsp;Financing cash flow for finance leases | 7194 | 4468 |
| Assets obtained in exchange for lease obligations: |  |  |
| &nbsp;&nbsp;&nbsp;Operating leases | $12292 | $10125 |
| &nbsp;&nbsp;&nbsp;Finance leases | 24495 | 16909 |

---

------

Supplemental balance sheet information related to leases was as follows:

---

| | | |
|:---|:---|:---|
| | June 28,<br>2025 | September 28,<br>2024 |
| <u>Operating Leases:</u> |  |  |
| Operating lease right-of-use assets | $52877 | $52591 |
| Accrued liabilities and other | $11362 | $11124 |
| Other long-term liabilities | 53454 | 53228 |
| Total operating lease liabilities | $64816 | $64352 |
| <u>Finance Leases:</u> |  |  |
| Property, plant, and equipment, at cost | $149534 | $123314 |
| Accumulated depreciation | (24662) | (14875) |
| Property, plant, and equipment, net | $124872 | $108439 |
| Accrued liabilities and other | $13498 | $9198 |
| Other long-term liabilities | 114799 | 100146 |
| Total finance lease liabilities | $128297 | $109344 |
| <u>Weighted average remaining lease term in years:</u> |  |  |
| Operating leases | 6.4 | 6.2 |
| Finance leases | 18.3 | 20.1 |
| <u>Weighted average discount rates:</u> |  |  |
| Operating leases | 5.2% | 5.2% |
| Finance leases | 6.4% | 6.4% |

---

Maturities of lease liabilities were as follows:

---

| | | |
|:---|:---|:---|
| | June 28, 2025 | June 28, 2025 |
| | Operating Leases | Finance Leases |
| 2025 | $3601 | $4811 |
| 2026 | 14110 | 20807 |
| 2027 | 12933 | 18394 |
| 2028 | 11175 | 19311 |
| 2029 | 9719 | 20332 |
| Thereafter | 25166 | 158630 |
| Total lease payments | 76704 | 242285 |
| Less: imputed interest | (11888) | (113988) |
| Total | $64816 | $128297 |

---

------

<u>[**Table of Contents**](#ie7d2cf4f294a4c48b9da5fb075e0f93b_7)</u>

**Note 8 - Goodwill and Intangible Assets**

The changes in the carrying amount of goodwill are as follows:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | Space and<br>Defense | Military Aircraft | Commercial Aircraft | Industrial | Total |
| Balance at September 28, 2024 | $259551 | $118942 | $92612 | $362659 | $833764 |
| Held for sale | (40000) |  |  |  | (40000) |
| Foreign currency translation | 23 | 1285 |  | 7017 | 8325 |
| Balance at June 28, 2025 | $219574 | $120227 | $92612 | $369676 | $802089 |

---

Goodwill in our Space and Defense segment is net of a $4,800 accumulated impairment loss at June 28, 2025. Goodwill in our Medical Devices reporting unit, included in our Industrial segment, is net of a $38,200 accumulated impairment loss at June 28, 2025.

The components of intangible assets are as follows:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | | June 28, 2025 | June 28, 2025 | September 28, 2024 | September 28, 2024 |
| | Weighted-<br>Average<br>Life (years) | Gross Carrying<br>Amount | Accumulated<br>Amortization | Gross Carrying<br>Amount | Accumulated<br>Amortization |
| Customer-related | 11 | $130489 | $(99688) | $130092 | $(96307) |
| Technology-related | 9 | 67314 | (57048) | 68275 | (56236) |
| Program-related | 23 | 40586 | (26587) | 39865 | (24887) |
| Marketing-related | 8 | 21255 | (19155) | 22141 | (19486) |
| Other | 3 | 1476 | (1460) | 1407 | (1385) |
| Intangible assets | 12 | $261120 | $(203938) | $261780 | $(198301) |

---

All acquired intangible assets other than goodwill are being amortized. Customer-related intangible assets primarily consist of customer relationships. Technology-related intangible assets primarily consist of technology, patents and intellectual property. Program-related intangible assets consist of long-term programs represented by current contracts and probable follow-on work. Marketing-related intangible assets primarily consist of trademarks and trade names.

Amortization of acquired intangible assets is as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | Three Months Ended | Three Months Ended | Nine Months Ended | Nine Months Ended |
| | June 28,<br>2025 | June 29,<br>2024 | June 28,<br>2025 | June 29,<br>2024 |
| Acquired intangible asset amortization | $2364 | $2384 | $6988 | $7672 |

---

Based on acquired intangible assets recorded at June 28, 2025, amortization is estimated to be approximately:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | 2025 | 2026 | 2027 | 2028 | 2029 |
| Estimated future amortization of acquired intangible assets | $9800 | $9700 | $8700 | $7900 | $6300 |

---

------

<u>[**Table of Contents**](#ie7d2cf4f294a4c48b9da5fb075e0f93b_7)</u>

**Note 9 - Equity Method and Other Investments**

Investments and operating results in which we do not have a controlling interest but we do have the ability to exercise significant influence over operations are accounted for using the equity method of accounting. Net investment balances for equity method investments and joint ventures are included as Other assets in the Consolidated Condensed Balance Sheets and consist of:

---

| | | |
|:---|:---|:---|
| | June 28,<br>2025 | September 28,<br>2024 |
| Moog Aircraft Service Asia | $2246 | $1742 |
| Suffolk Technologies Fund 1, L.P. | 2663 | 1659 |
| Net investment balance | $4909 | $3401 |

---

We recorded the following gains and losses from equity method investments and joint ventures which are included in Other in the Consolidated Condensed Statements of Earnings:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | Three Months Ended | Three Months Ended | Nine Months Ended | Nine Months Ended |
| | June 28,<br>2025 | June 29,<br>2024 | June 28,<br>2025 | June 29,<br>2024 |
| Net gain (loss) |  |  |  |  |
| &nbsp;&nbsp;Equity method investments and joint ventures | $195 | $(52) | $446 | $219 |

---

Moog Aircraft Services Asia ("MASA") is a joint venture included in our Commercial Aircraft segment in which we currently hold a 51% ownership share. MASA is intended to provide maintenance, repair and overhaul services for our manufactured flight control systems.

Suffolk Technologies Fund 1, L.P., is a limited partnership included in our Industrial segment that invests in startups to transform the construction, real estate and property maintenance industries in the U.S. We have a remaining on-call capital commitment of up to $4,774.

Investments in, and the operating results of, entities in which we do not have a controlling financial interest or the ability to exercise significant influence over the operations are accounted for at historical cost or fair value using readily determinable financial information. During the three months ended June 28, 2025, we recorded a $3,000 impairment for the devaluation of an investment, which is included in Asset impairment in the Consolidated Condensed Statements of Earnings. As of June 28, 2025, we had investments of $1,580, which are included as Other assets in the Consolidated Condensed Balance Sheets.

------

<u>[**Table of Contents**](#ie7d2cf4f294a4c48b9da5fb075e0f93b_7)</u>

**Note 10 - Indebtedness**

We maintain short-term line of credit facilities with banks throughout the world that are principally demand lines subject to revision by the banks.

Long-term debt consists of:

---

| | | |
|:---|:---|:---|
| | June 28,<br>2025 | September 28,<br>2024 |
| U.S. revolving credit facility | $331500 | $375500 |
| Term loan | 250000 |  |
| SECT revolving credit facility | 1000 | 1000 |
| Senior notes 4.25% | 500000 | 500000 |
| Senior debt | 1082500 | 876500 |
| Less deferred debt issuance cost | (826) | (2361) |
| Long-term debt | $1081674 | $874139 |

---

Our U.S. revolving credit facility, which matures on October 27, 2027, has a capacity of $1,100,000 and provides an expansion option, which permits us to request an increase of up to $400,000 to the credit facility upon satisfaction of certain conditions. On May 30, 2025, we amended and restated our loan agreement to include a $250,000 term loan, with installment payments of $3,125 in 2026, $9,375 in 2027 and the remaining balance on the maturity date of October 27, 2027. Additional principal payments may be required under certain conditions. The proceeds of the term loan were used to pay down outstanding revolver borrowings of the U.S. revolving credit facility. Interest on our outstanding U.S. revolving credit facility and term loan borrowings are based on SOFR plus the applicable margin. The U.S. revolving credit facility and term loan are secured by substantially all of our U.S. assets and contain various covenants which, among others, specify interest coverage and maximum leverage. We are in compliance with all covenants.

On November 6, 2024, the SECT amended the revolving credit facility, which reduced the borrowing capacity from $35,000 to $25,000 and extended the maturity date from October 26, 2025 to October 26, 2026. Interest is based on SOFR plus an applicable margin. A commitment fee is also charged based on a percentage of the unused amounts available and is not material.

We have $500,000 aggregate principal amount of 4.25% senior notes due December 15, 2027 with interest paid semiannually on June 15 and December 15 of each year. The senior notes are unsecured obligations, guaranteed on a senior unsecured basis by certain subsidiaries and contain normal incurrence-based covenants and limitations such as the ability to incur additional indebtedness, pay dividends, make other restricted payments and investments, create liens and certain corporate acts such as mergers and consolidations. We are in compliance with all covenants.

------

<u>[**Table of Contents**](#ie7d2cf4f294a4c48b9da5fb075e0f93b_7)</u>

**Note 11 - Other Accrued Liabilities**

Other accrued liabilities consists of:

---

| | | |
|:---|:---|:---|
| | June 28,<br>2025 | September 28, 2024 |
| Employee benefits | $64506 | $55032 |
| Contract reserves | 69832 | 71554 |
| Warranty accrual | 23745 | 23548 |
| Accrued income taxes | 30318 | 52007 |
| Other | 114113 | 103039 |
| Other accrued liabilities | $302514 | $305180 |

---

In the ordinary course of business, we warrant our products against defects in design, materials and workmanship typically over periods ranging from twelve to sixty months. We determine warranty reserves needed by product line based on historical experience and current facts and circumstances. Activity in the warranty accrual is summarized as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | Three Months Ended | Three Months Ended | Nine Months Ended | Nine Months Ended |
| | June 28,<br>2025 | June 29,<br>2024 | June 28,<br>2025 | June 29,<br>2024 |
| Warranty accrual at beginning of period | $21782 | $23616 | $23548 | $22939 |
| Warranties issued during current period | 2763 | 402 | 6317 | 5692 |
| Adjustments to pre-existing warranties | 1226 | (837) | 549 | (1518) |
| Reductions for settling warranties | (2404) | (429) | (6809) | (4453) |
| Foreign currency translation | 378 | (47) | 140 | 45 |
| Warranty accrual at end of period | $23745 | $22705 | $23745 | $22705 |

---

**Note 12 - Derivative Financial Instruments** 

We principally use derivative financial instruments to manage foreign exchange risk related to foreign operations and foreign currency transactions and interest rate risk associated with long-term debt. We enter into derivative financial instruments with a number of major financial institutions to minimize counterparty credit risk.

<u>Derivatives designated as hedging instruments</u>

We use foreign currency contracts as cash flow hedges to effectively fix the exchange rates on future payments and revenue. To mitigate exposure in movements between various currencies, including the Philippine peso, we had

outstanding foreign currency contracts with notional amounts of $45,035 at June 28, 2025. These contracts mature at various times through December 23, 2026.

We use forward currency contracts to hedge our net investment in certain foreign subsidiaries. As of June 28, 2025, we had no outstanding net investment hedges.

Interest rate swaps are used to adjust the proportion of total debt that is subject to variable and fixed interest rates. The interest rate swaps are designated as hedges of the amount of future cash flows related to interest payments on variable-rate debt that, in combination with the interest payments on the debt, convert a portion of the variable-rate debt to fixed-rate debt. At June 28, 2025, we had no outstanding interest rate swaps.

Foreign currency contracts, net investment hedges and interest rate swaps are recorded in the Consolidated Condensed Balance Sheets at fair value and the related gains or losses are deferred in Shareholders' Equity as a component of Accumulated Other Comprehensive Income (Loss) ("AOCIL"). These deferred gains and losses are reclassified into the Consolidated Condensed Statements of Earnings, as necessary, during the periods in which the related payments or receipts affect earnings. However, to the extent the foreign currency contracts and interest rate swaps are not perfectly effective in offsetting the change in the value of the payments and revenue being hedged, the ineffective portion of these contracts is recognized in earnings immediately. Ineffectiveness was not material in the first nine months of 2025 or 2024.

------

<u>[**Table of Contents**](#ie7d2cf4f294a4c48b9da5fb075e0f93b_7)</u>

<u>Derivatives not designated as hedging instruments</u>

We also have foreign currency exposure on balances, primarily intercompany, that are denominated in a foreign

currency and are adjusted to current values using period-end exchange rates. The resulting gains or losses are recorded in the Consolidated Condensed Statements of Earnings. To minimize foreign currency exposure, we have foreign currency contracts with notional amounts of $174,421 at June 28, 2025. The foreign currency contracts are recorded in the Consolidated Condensed Balance Sheets at fair value and resulting gains or losses are recorded in the Consolidated Condensed Statements of Earnings. We recorded the following gains and losses on foreign currency contracts which are included in other income or expense and generally offset the gains or losses from the foreign currency adjustments on the intercompany balances that are also included in other income or expense:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | | Three Months Ended | Three Months Ended | Nine Months Ended | Nine Months Ended |
| |<br>Statements of Earnings location | June 28,<br>2025 | June 29,<br>2024 | June 28,<br>2025 | June 29,<br>2024 |
| Net gain (loss) |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Foreign currency contracts | Other | $13048 | $(2542) | $4310 | $(1009) |

---

<u>Summary of derivatives</u>

The fair value and classification of derivatives is summarized as follows:

---

| | | | |
|:---|:---|:---|:---|
| | Balance Sheets location | June 28,<br>2025 | September 28,<br>2024 |
| Derivatives designated as hedging instruments: |  |  |  |
| &nbsp;&nbsp;&nbsp;Foreign currency contracts | Other current assets | $1184 | $— |
| &nbsp;&nbsp;&nbsp;Foreign currency contracts | Other assets | 318 |  |
|  | Total asset derivatives | $1502 | $— |
| &nbsp;&nbsp;&nbsp;Foreign currency contracts | Other long-term liabilities | 7 |  |
|  | Total liability derivatives | $7 | $— |
| Derivatives not designated as hedging instruments: |  |  |  |
| &nbsp;&nbsp;&nbsp;Foreign currency contracts | Other current assets | $3162 | $648 |
| &nbsp;&nbsp;&nbsp;Foreign currency contracts | Accrued liabilities and other | $8 | $28 |

---

------

<u>[**Table of Contents**](#ie7d2cf4f294a4c48b9da5fb075e0f93b_7)</u>

**Note 13 - Fair Value**

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Depending on the nature of the asset or liability, various techniques and assumptions can be used to estimate fair value. The definition of the fair value hierarchy is as follows:

Level 1 – Quoted prices in active markets for identical assets and liabilities.

Level 2 – Observable inputs other than quoted prices in active markets for similar assets and liabilities.

Level 3 – Inputs for which significant valuation assumptions are unobservable in a market and therefore value is based on the best available data, some of which is internally developed and considers risk premiums that a market participant would require.

Our derivatives are valued using various pricing models or discounted cash flow analyses that incorporate observable market data, such as interest rate yield curves and currency rates, and are classified as Level 2 within the valuation hierarchy.

The following table presents the fair values and classification of our financial assets and liabilities measured on a recurring basis, all of which are classified as Level 2, except for the acquisition contingent consideration, which is classified as Level 3:

---

| | | | |
|:---|:---|:---|:---|
| | Balance Sheets location | June 28,<br>2025 | September 28,<br>2024 |
| Foreign currency contracts | Other current assets | $4346 | $648 |
| Foreign currency contracts | Other assets | 318 |  |
|  | Total assets | $4664 | $648 |
| Foreign currency contracts | Accrued liabilities and other | $8 | $28 |
| Foreign currency contracts | Other long-term liabilities | 7 |  |
| Acquisition contingent consideration | Accrued liabilities and other | 673 | 2839 |
|  | Total liabilities | $688 | $2867 |

---

The changes in financial liabilities classified as Level 3 within the fair value hierarchy are as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | Three Months Ended | Three Months Ended | Nine Months Ended | Nine Months Ended |
| | June 28,<br>2025 | June 29,<br>2024 | June 28,<br>2025 | June 29,<br>2024 |
| Balance at beginning of period | $873 | $3256 | $2839 | $3089 |
| Increase in discounted future cash flows recorded as interest expense |  | 83 |  | 250 |
| Increase in earn out provisions recorded as other expense |  |  | 76 |  |
| Settlements paid in cash | (200) |  | (2242) |  |
| Balance at end of period | $673 | $3339 | $673 | $3339 |

---

Our only financial instrument for which the carrying value differs from its fair value is long-term debt. At June 28, 2025, the fair value of long-term debt was $1,068,433 compared to its carrying value of $1,082,500. The fair value of long-term debt is classified as Level 2 within the fair value hierarchy and was estimated based on quoted market prices.

------

<u>[**Table of Contents**](#ie7d2cf4f294a4c48b9da5fb075e0f93b_7)</u>

**Note 14 - Restructuring**

The 2023 plan has elements, primarily retention agreements, that will continue through 2027 and could result in additional costs of up to approximately $3,500.

Restructuring activity for severance and other costs by segment and reconciliation to consolidated amounts is as follows:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | Space and Defense | Military Aircraft | Commercial Aircraft | Industrial | Total |
| Balance at September 28, 2024 | $1400 | $624 | $760 | $9394 | $12178 |
| Charged to expense - 2024 plan | 1266 |  |  | 6549 | 7815 |
| Charged to expense - 2023 plan |  |  |  | 1244 | 1244 |
| Adjustments to provision |  |  |  | (574) | (574) |
| Non-cash charges - 2024 plan | (530) |  |  | (733) | (1263) |
| Cash payments - 2024 plan | (426) | (624) | (760) | (7628) | (9438) |
| Cash payments - 2023 plan |  |  |  | (1069) | (1069) |
| Cash payments - 2022 plan |  |  |  | (32) | (32) |
| Cash payments - 2020 plan |  |  |  | (170) | (170) |
| Cash payments - 2018 plan |  |  |  | (384) | (384) |
| Foreign currency translation | 318 |  |  | 386 | 704 |
| Balance at June 28, 2025 | $2028 | $— | $— | $6983 | $9011 |

---

As of June 28, 2025, the restructuring accrual consists of $3,841 for the 2024 plan, $4,322 for the 2023 plan, $193 for the 2022 plan, $85 for the 2020 plan and $570 for the 2018 plan. Restructuring is expected to be paid within a year, except portions classified as long-term liabilities based on the nature of the reserve and the timing of the expected payments.

**Note 15 - Employee Benefit Plans**

Pension expense for our defined contribution plans consists of:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | Three Months Ended | Three Months Ended | Nine Months Ended | Nine Months Ended |
| | June 28,<br>2025 | June 29,<br>2024 | June 28,<br>2025 | June 29,<br>2024 |
| U.S. defined contribution plans | $13689 | $13094 | $37996 | $38456 |
| Non-U.S. defined contribution plans | 2762 | 2350 | 7906 | 7301 |
| Total expense for defined contribution plans | $16451 | $15444 | $45902 | $45757 |

---

Net periodic benefit costs for our defined benefit pension plans are as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | Three Months Ended | Three Months Ended | Nine Months Ended | Nine Months Ended |
| | June 28,<br>2025 | June 29,<br>2024 | June 28,<br>2025 | June 29,<br>2024 |
| U.S. Plans |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Service cost | $2470 | $2694 | $7411 | $8081 |
| &nbsp;&nbsp;&nbsp;Interest cost | 6725 | 6973 | 20173 | 20919 |
| &nbsp;&nbsp;&nbsp;Expected return on plan assets | (7901) | (6817) | (23701) | (20450) |
| &nbsp;&nbsp;&nbsp;Amortization of actuarial loss | 2977 | 3072 | 8931 | 9216 |
| Expense for U.S. defined benefit plans | $4271 | $5922 | $12814 | $17766 |
| Non-U.S. Plans |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Service cost | $787 | $645 | $2318 | $1948 |
| &nbsp;&nbsp;&nbsp;Interest cost | 1349 | 1422 | 3943 | 4272 |
| &nbsp;&nbsp;&nbsp;Expected return on plan assets | (1067) | (1098) | (3129) | (3301) |
| &nbsp;&nbsp;&nbsp;Amortization of prior service cost | 14 | 14 | 43 | 42 |
| &nbsp;&nbsp;&nbsp;Amortization of actuarial loss | 197 | 52 | 573 | 156 |
| Expense for non-U.S. defined benefit plans | $1280 | $1035 | $3748 | $3117 |

---

------

**Note 16 - Income Taxes**

The effective tax rate for the three and nine months ended June 28, 2025 was 23.4% and 23.4%, respectively. The effective tax rate for the three and nine months ended June 29, 2024 was 20.5% and 22.7%, respectively. The effective tax rates for the three and nine months ended June 28, 2025 and June 29, 2024 are different than the U.S. federal statutory tax rate of 21% due to tax on earnings generated outside the U.S. with higher statutory rates and U.S. state income taxes, partially offset by research and development tax credits and provision to tax return adjustments.

On July 4, 2025, the U.S. enacted a budget reconciliation package known as the One Big Beautiful Bill Act of 2025 ("OBBBA"). Changes in tax laws may affect recorded deferred tax assets and deferred tax liabilities and our effective tax rate in the future and we continue to evaluate the impacts that OBBBA will have on our Condensed Consolidated Financial Statements. We do not expect any material change to our ongoing tax rate as a result of this legislation.

------

<u>[**Table of Contents**](#ie7d2cf4f294a4c48b9da5fb075e0f93b_7)</u>

**Note 17 - Accumulated Other Comprehensive Income (Loss)**

The changes in AOCIL, net of tax, by component for the nine months ended June 28, 2025 are as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | Accumulated foreign currency translation | Accumulated retirement liability | Accumulated gain (loss) on derivatives | Total |
| AOCIL at September 28, 2024 | $(95538) | $(108231) | $— | $(203769) |
| OCI before reclassifications | 23709 | (613) | 1456 | 24552 |
| Amounts reclassified from AOCIL | 10963 | 6541 | (290) | 17214 |
| OCI, net of tax | 34672 | 5928 | 1166 | 41766 |
| AOCIL at June 28, 2025 | $(60866) | $(102303) | $1166 | $(162003) |

---

Net gains and losses on net investment hedges are recorded in Accumulated foreign currency translation to the extent that the instruments are effective in hedging the designated risk.

The amounts reclassified from AOCIL into earnings are as follows:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | | Three Months Ended | Three Months Ended | Nine Months Ended | Nine Months Ended |
| |<br>Statements of Earnings location | June 28,<br>2025 | June 29,<br>2024 | June 28,<br>2025 | June 29,<br>2024 |
| Retirement liability: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Prior service cost |  | $14 | $14 | $43 | $42 |
| &nbsp;&nbsp;&nbsp;Actuarial losses |  | 2827 | 2659 | 8461 | 7977 |
| Reclassification from AOCIL into earnings | Reclassification from AOCIL into earnings | 2841 | 2673 | 8504 | 8019 |
| Tax effect |  | (655) | (628) | (1963) | (1885) |
| Net reclassification from AOCIL into earnings | Net reclassification from AOCIL into earnings | $2186 | $2045 | $6541 | $6134 |
| Derivatives: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Foreign currency contracts | Cost of sales | $(349) | $— | $(379) | $588 |
| Reclassification from AOCIL into earnings | Reclassification from AOCIL into earnings | (349) |  | (379) | 588 |
| Tax effect |  | 82 |  | 89 | (139) |
| Net reclassification from AOCIL into earnings | Net reclassification from AOCIL into earnings | $(267) | $— | $(290) | $449 |
| Foreign currency translation: |  |  |  |  |  |
| &nbsp;&nbsp;Business dispositions | Other | $(39) | $1 | $10963 | $(10) |
| Reclassification from AOCIL into earnings | Reclassification from AOCIL into earnings | (39) | 1 | 10963 | (10) |
| Tax effect |  |  |  |  |  |
| Net reclassification from AOCIL into earnings | Net reclassification from AOCIL into earnings | $(39) | $1 | $10963 | $(10) |

---

Reclassification from AOCIL into earnings for the Retirement liability are included in the computation of non-service pension expense, which is included in Other on the Consolidated Condensed Statement of Earnings.

The effective portion of amounts deferred in AOCIL are as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | Three Months Ended | Three Months Ended | Nine Months Ended | Nine Months Ended |
| | June 28,<br>2025 | June 29,<br>2024 | June 28,<br>2025 | June 29,<br>2024 |
| Foreign currency contracts | $1009 | $— | $1906 | $90 |
| Net gain (loss) | 1009 |  | 1906 | 90 |
| Tax effect | (238) |  | (450) | (21) |
| Net deferral in AOCIL of derivatives | $771 | $— | $1456 | $69 |

---

------

<u>[**Table of Contents**](#ie7d2cf4f294a4c48b9da5fb075e0f93b_7)</u>

**Note 18 - Stock Employee Compensation Trust and Supplemental Retirement Plan Trust**

The SECT assists in administering and provides funding for equity-based compensation plans and benefit programs, including the Moog Inc. Retirement Savings Plan ("RSP"), RSP(+) and the Employee Stock Purchase Plan ("ESPP"). The SERP Trust provides funding for benefits under the SERP provisions of the Moog Inc. Plan to Equalize Retirement Income and Supplemental Retirement Income. Both the SECT and the SERP Trust hold Moog shares as investments. The shares in the SECT and SERP Trust are not considered outstanding for purposes of calculating earnings per share. However, in accordance with the trust agreements governing the SECT and SERP Trust, the trustees vote all shares held by the SECT and SERP Trust on all matters submitted to shareholders.

**Note 19 - Earnings per Share**

Basic and diluted weighted-average shares outstanding, as well as shares considered to be anti-dilutive, are as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | Three Months Ended | Three Months Ended | Nine Months Ended | Nine Months Ended |
| | June 28,<br>2025 | June 29,<br>2024 | June 28,<br>2025 | June 29,<br>2024 |
| Basic weighted-average shares outstanding | 31524999 | 31960165 | 31684945 | 31943365 |
| Dilutive effect of equity-based awards | 371950 | 449205 | 397241 | 399335 |
| Diluted weighted-average shares outstanding | 31896949 | 32409370 | 32082186 | 32342700 |

---

---

| | | | |
|:---|:---|:---|:---|
| Anti-dilutive shares from equity-based awards | 231 | 227 | 1,547 |

---

**Note 20 - Segments**

Disaggregation of net sales by segment for the three and nine months ended June 28, 2025 and June 29, 2024 are as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | Three Months Ended | Three Months Ended | Nine Months Ended | Nine Months Ended |
| **Market Type** | June 28,<br>2025 | June 29,<br>2024 | June 28,<br>2025 | June 29,<br>2024 |
| Net sales: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Space | $118664 | $108965 | $348869 | $322272 |
| &nbsp;&nbsp;&nbsp;Defense | 169041 | 149444 | 456804 | 433052 |
| Space and Defense | 287705 | 258409 | 805673 | 755324 |
| &nbsp;&nbsp;&nbsp;Original Equipment Manufacturers | 177110 | 160691 | 508483 | 455673 |
| &nbsp;&nbsp;&nbsp;Aftermarket | 47552 | 46486 | 143448 | 140248 |
| Military Aircraft | 224662 | 207177 | 651931 | 595921 |
| &nbsp;&nbsp;&nbsp;Original Equipment Manufacturers | 133604 | 132374 | 410329 | 402357 |
| &nbsp;&nbsp;&nbsp;Aftermarket | 85832 | 56991 | 246411 | 188824 |
| Commercial Aircraft | 219436 | 189365 | 656740 | 591181 |
| &nbsp;&nbsp;&nbsp;Energy | 34481 | 37168 | 101699 | 104442 |
| &nbsp;&nbsp;&nbsp;Industrial Automation | 106168 | 109100 | 297345 | 341474 |
| &nbsp;&nbsp;&nbsp;Simulation and Test | 36289 | 40019 | 106598 | 115577 |
| &nbsp;&nbsp;&nbsp;Medical | 62622 | 63497 | 196532 | 187969 |
| Industrial | 239560 | 249784 | 702174 | 749462 |
| Net sales | $971363 | $904735 | $2816518 | $2691888 |

---

------

<u>[**Table of Contents**](#ie7d2cf4f294a4c48b9da5fb075e0f93b_7)</u>

---

| | | | | |
|:---|:---|:---|:---|:---|
| | Three Months Ended | Three Months Ended | Nine Months Ended | Nine Months Ended |
| **Customer Type** | June 28,<br>2025 | June 29,<br>2024 | June 28,<br>2025 | June 29,<br>2024 |
| Net sales: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Commercial | $92046 | $49916 | $183155 | $129253 |
| &nbsp;&nbsp;&nbsp;U.S. Government (including OEM) | 164443 | 178636 | 538987 | 553261 |
| &nbsp;&nbsp;&nbsp;Other | 31216 | 29857 | 83531 | 72810 |
| Space and Defense | 287705 | 258409 | 805673 | 755324 |
| &nbsp;&nbsp;&nbsp;U.S. Government (including OEM) | 165083 | 148928 | 484924 | 424539 |
| &nbsp;&nbsp;&nbsp;Other | 59579 | 58249 | 167007 | 171382 |
| Military Aircraft | 224662 | 207177 | 651931 | 595921 |
| &nbsp;&nbsp;&nbsp;Commercial | 208561 | 179384 | 627020 | 564612 |
| &nbsp;&nbsp;&nbsp;Other | 10875 | 9981 | 29720 | 26569 |
| Commercial Aircraft | 219436 | 189365 | 656740 | 591181 |
| &nbsp;&nbsp;&nbsp;Commercial | 229089 | 244834 | 685016 | 737028 |
| &nbsp;&nbsp;&nbsp;U.S. Government (including OEM) | 2308 | 3226 | 5005 | 8150 |
| &nbsp;&nbsp;&nbsp;Other | 8163 | 1724 | 12153 | 4284 |
| Industrial | 239560 | 249784 | 702174 | 749462 |
| &nbsp;&nbsp;&nbsp;Commercial | 529696 | 474134 | 1495191 | 1430893 |
| &nbsp;&nbsp;&nbsp;U.S. Government (including OEM) | 331834 | 330790 | 1028916 | 985950 |
| &nbsp;&nbsp;&nbsp;Other | 109833 | 99811 | 292411 | 275045 |
| Net sales | $971363 | $904735 | $2816518 | $2691888 |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| | Three Months Ended | Three Months Ended | Nine Months Ended | Nine Months Ended |
| **Revenue Recognition Method** | June 28,<br>2025 | June 29,<br>2024 | June 28,<br>2025 | June 29,<br>2024 |
| Net sales: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Over-time | $254222 | $226405 | $720254 | $679231 |
| &nbsp;&nbsp;&nbsp;Point in time | 33483 | 32004 | 85419 | 76093 |
| Space and Defense | 287705 | 258409 | 805673 | 755324 |
| &nbsp;&nbsp;&nbsp;Over-time | 184720 | 168248 | 542353 | 482163 |
| &nbsp;&nbsp;&nbsp;Point in time | 39942 | 38929 | 109578 | 113758 |
| Military Aircraft | 224662 | 207177 | 651931 | 595921 |
| &nbsp;&nbsp;&nbsp;Over-time | 142789 | 149220 | 458863 | 449230 |
| &nbsp;&nbsp;&nbsp;Point in time | 76647 | 40145 | 197877 | 141951 |
| Commercial Aircraft | 219436 | 189365 | 656740 | 591181 |
| &nbsp;&nbsp;Over-time | 27440 | 40894 | 82680 | 107405 |
| &nbsp;&nbsp;&nbsp;Point in time | 212120 | 208890 | 619494 | 642057 |
| Industrial | 239560 | 249784 | 702174 | 749462 |
| &nbsp;&nbsp;Over-time | 609171 | 584767 | 1804150 | 1718029 |
| &nbsp;&nbsp;&nbsp;Point in time | 362192 | 319968 | 1012368 | 973859 |
| Net sales | $971363 | $904735 | $2816518 | $2691888 |

---

------

<u>[**Table of Contents**](#ie7d2cf4f294a4c48b9da5fb075e0f93b_7)</u>

Operating profit is net sales less cost of sales and other operating expenses, excluding interest expense, equity-based compensation expense, non-service pension expense and other corporate expenses. Cost of sales and other operating expenses are directly identifiable to the respective segment or allocated on the basis of sales, manpower or profit. Operating profit by segment and reconciliations for the three and nine months ended June 28, 2025 and June 29, 2024 are as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | Three Months Ended | Three Months Ended | Nine Months Ended | Nine Months Ended |
| | June 28,<br>2025 | June 29,<br>2024 | June 28,<br>2025 | June 29,<br>2024 |
| Operating profit: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Space and Defense | $38261 | $32635 | $99581 | $100175 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Military Aircraft | 17994 | 23965 | 64632 | 60323 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Commercial Aircraft | 32623 | 24367 | 82418 | 69838 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Industrial | 22989 | 24413 | 75700 | 81592 |
| Total operating profit | 111867 | 105380 | 322331 | 311928 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Deductions from operating profit: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Interest expense | 17790 | 18153 | 54340 | 52850 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Equity-based compensation expense | 4649 | 4089 | 12669 | 11301 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Non-service pension expense | 1970 | 3188 | 5855 | 9566 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Corporate and other expenses, net | 9476 | 9045 | 29327 | 25946 |
| Earnings before income taxes | $77982 | $70905 | $220140 | $212265 |

---

------

<u>[**Table of Contents**](#ie7d2cf4f294a4c48b9da5fb075e0f93b_7)</u>

**Note 21 - Related Party Transactions**

Our transactions with related parties were not material for the three and nine months ended June 28, 2025.

**Note 22 - Commitments and Contingencies**

From time to time, we are involved in legal proceedings. We are not a party to any pending legal proceedings which management believes will result in a material adverse effect on our financial condition, results of operations or cash flows.

We are engaged in administrative proceedings with governmental agencies and legal proceedings with governmental agencies and other third parties in the normal course of our business, including litigation under Superfund laws, regarding environmental matters. We believe that adequate reserves have been established for our share of the estimated cost for all currently pending environmental administrative or legal proceedings and do not expect that these environmental matters will have a material adverse effect on our financial condition, results of operations or cash flows.

In the ordinary course of business we could be subject to ongoing claims or disputes from our customers, the ultimate settlement of which could have a material adverse impact on our consolidated results of operations. While the receivables and any loss provisions recorded to date reflect management's best estimate of the projected costs to complete a given project, there is still significant effort required to complete the ultimate deliverable. Future variability in internal cost and future profitability is dependent upon a number of factors including deliveries, performance and government budgetary pressures. The inability to achieve a satisfactory contractual solution, further unplanned delays, additional developmental cost growth or variations in any of the estimates used in the existing contract analysis could lead to further loss provisions. Additional losses could have a material adverse impact on our financial condition, results of operations or cash flows in the period in which the loss may be recognized.

We are contingently liable for $13,421 related to standby letters of credit issued by banks to third parties on our behalf at June 28, 2025.

**Note 23 - Subsequent Event**

On July 24, 2025, we declared a $0.29 per share quarterly dividend payable on issued and outstanding shares of our Class A and Class B common stock on August 26, 2025 to shareholders of record at the close of business on August 8, 2025.

On July 1, 2025, we acquired COTSWORKS, Inc., based in Ohio for cash and Moog Class A shares. See Note 3 - Acquisitions, Divestitures and Assets Held for Sale for additional disclosures.

------

<u>[**Table of Contents**](#ie7d2cf4f294a4c48b9da5fb075e0f93b_7)</u>

**Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations.**

The following should be read in conjunction with Management's Discussion and Analysis of Financial Condition and Results of Operations contained in the Company's Annual Report filed on Form 10-K for the fiscal year ended September 28, 2024. In addition, the following should be read in conjunction with our Consolidated Financial Statements and Notes to Consolidated Condensed Financial Statements contained herein. All references to years in this Management's Discussion and Analysis of Financial Condition and Results of Operations are to fiscal years. Amounts may differ due to rounding as dollar and percentage variances are computed based on reported values.

**OVERVIEW**

We are a worldwide designer, manufacturer and systems integrator of high performance precision motion and fluid controls and control systems for a broad range of applications in aerospace and defense and industrial markets.

Within the aerospace and defense market, our products and systems include:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Defense market - primary and secondary flight controls and components for military aircraft, turreted weapon systems, tactical and strategic missile steering controls and various defense product components.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Commercial aircraft market - primary and secondary flight controls and components for commercial aircraft.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Space market - satellite avionics, positioning controls and components, launcher thrust vector controls and components, as well as integrated space vehicles.

In the industrial market, our products are used in a wide range of applications including:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Industrial market - various components and systems used in various applications including heavy industrial machinery used for metal forming and pressing, flight simulation motion control systems, energy exploration and generation products, material and automotive structural and fatigue testing systems, high efficiency pumps used in data center cooling applications, as well as for the electrification of construction vehicles.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Medical market - components and pumps for enteral clinical nutrition and infusion therapy, CT scan medical equipment, ultrasonic sensors and surgical handpieces and sleep apnea equipment.

We operate under four segments, Space and Defense, Military Aircraft, Commercial Aircraft and Industrial. Our principal manufacturing facilities are located in the United States, Philippines, United Kingdom, Germany, Italy, Costa Rica, China, Netherlands, Japan, Canada, India and Lithuania.

Under ASC 606, 63% of revenue was recognized over time for the three months ended June 28, 2025, using the cost-to-cost method of accounting. The over-time method of revenue recognition is predominantly used in Space and Defense, Military Aircraft and Commercial Aircraft. We use this method for U.S. Government contracts and repair and overhaul arrangements as we are creating or enhancing assets that the customer controls. In addition, many of our large commercial contracts qualify for over-time accounting as our performance does not create an asset with an alternative use and we have an enforceable right to payment for performance completed to date.

For the three months ended June 28, 2025, 37% of revenue was recognized at the point in time control transferred to the customer. This method of revenue recognition is used most frequently in Industrial. We use this method for commercial contracts in which the asset being created has an alternative use. We determine the point in time control transfers to the customer by weighing the five indicators provided by ASC 606. When control has transferred to the customer, profit is generated as cost of sales is recorded and as revenue is recognized.

Our products and technologies affect the lives of millions of people around the world. Our solutions are critical to preserving national security, ensuring safe air transportation, reducing factory emissions and enhancing patient's lives all while driving innovation. Our engineers collaboratively design and manufacture the most advanced motion control products, to the highest quality standards, for use in demanding applications. By capitalizing on these core foundational strengths, we believe we have achieved a leadership position in the high performance precision controls market and are "Shaping the way our world moves™."

------

<u>[**Table of Contents**](#ie7d2cf4f294a4c48b9da5fb075e0f93b_7)</u>

By leveraging our engineering heritage and by focusing on customer intimacy to solve our customers' most demanding technical problems, we have been able to expand our control product franchise to multiple markets; organically growing from a high-performance components manufacturer to a high-performance systems designer, manufacturer and integrator. In addition, we continue to expand our content positions on our current platforms, seeking to be the leading supplier in the niche markets we serve. We also look for innovation in all aspects of our business, employing new technologies to improve productivity, while focusing on talent development to strengthen our employee operational performance.

Our fundamental long-term strategies that will help us achieve our financial objectives center around pricing and simplification initiatives. Our pricing initiatives focus on receiving recognition for the value we deliver to our customers across all of our markets. Our simplification initiatives center around 80/20 methodologies and include:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• shaping our product and business portfolio to invest in growth areas and to divest those that no longer fit,

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• rationalizing our footprint to align with current and future business levels,

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• focusing our factories so that individual manufacturing sites meet the unique needs of a specific market, and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• investing in automation and technologies to improve business operations.

We focus on improving shareholder value through strategic revenue growth, both organic and acquired, improving operating efficiencies and utilizing low cost manufacturing facilities without compromising quality. Over time, we strive to have a balanced approach to capital allocation in order to maximize shareholder returns. Investing for organic growth through increased capital expenditures is a key element of our capital allocation strategy. Also, we have repurchased shares opportunistically, acquired businesses and remain committed to our dividend policy.

**Acquisitions, Divestitures an Assets Held for Sale**

See Note 3 - Assets, Divestitures and Assets Held for Sale in the Consolidated Financial Statements included in Item 1, Financial Statements of this report for details.

**CRITICAL ACCOUNTING POLICIES**

On a regular basis, we evaluate the critical accounting policies used to prepare our consolidated financial statements, including revenue recognition on long-term contracts, contract reserves, reserves for inventory valuation, reviews for impairment of goodwill, reviews for impairment of long-lived assets, pension assumptions and income taxes.

**RECENT ACCOUNTING PRONOUNCEMENTS**

See Note 1 - Basis of Presentation in the Consolidated Condensed Financial Statements included in Item 1, Financial Statements of this report for further information regarding Financial Accounting Standards Board issued ASUs.

------

<u>[**Table of Contents**](#ie7d2cf4f294a4c48b9da5fb075e0f93b_7)</u>

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **CONSOLIDATED RESULTS OF OPERATIONS** | **CONSOLIDATED RESULTS OF OPERATIONS** | **CONSOLIDATED RESULTS OF OPERATIONS** | **CONSOLIDATED RESULTS OF OPERATIONS** | **CONSOLIDATED RESULTS OF OPERATIONS** | | | | |
|  | Three Months Ended | Three Months Ended | Three Months Ended | Three Months Ended | Nine Months Ended | Nine Months Ended | Nine Months Ended | Nine Months Ended |
| (In millions, except per share data) | June 28, 2025 | June 29, 2024 | $ Variance | % Variance | June 28, 2025 | June 29, 2024 | $ Variance | % Variance |
| Net sales | $971 | $905 | $67 | 7% | $2817 | $2692 | $125 | 5% |
| Gross margin | *27.4 %* | *27.8 %* |  |  | *27.1 %* | *27.9 %* |  |  |
| Research and development expenses | 22 | 28 | (6) | (21%) | 70 | 87 | (17) | (19%) |
| Selling, general and administrative expenses as a percentage of sales | *14.3 %* | *14.0 %* |  |  | *14.2 %* | *13.7 %* |  |  |
| Interest expense | 18 | 18 |  | (2%) | 54 | 53 | 1 | 3% |
| Asset impairment | 3 |  | 3 | N/M | 3 | 7 | (4) | N/M |
| Restructuring expense | 3 | 4 | (1) | N/M | 9 | 13 | (4) | N/M |
| Other | 4 | 4 | (1) | (16%) | 8 | 10 | (2) | (21%) |
| Effective tax rate | *23.4 %* | *20.5 %* |  |  | *23.4 %* | *22.7 %* |  |  |
| Net earnings | $60 | $56 | $3 | 6% | $169 | $164 | $4 | 3% |
| Diluted earnings per share | $1.87 | $1.74 | $0.13 | 7% | $5.25 | $5.08 | $0.17 | 3% |
| Twelve-month backlog |  |  |  |  | $2650 | $2450 | $200 | 8% |

---

Net sales increased in the third quarter and in the first three quarters of 2025 compared to the third quarter and the first three quarters of 2024, driven by demand in Commercial Aircraft and by defense market growth in Space and Defense and Military Aircraft. These increases were partially offset by a decrease in Industrial, driven by the lost sales associated with our divestitures and simplification actions.

Gross margin decreased in the third quarter of 2025 compared to the third quarter of 2024, driven by inventory write-downs of $6 million, primarily within Industrial and Military Aircraft. Gross margin decreased in the first three quarters of 2025 compared to the first three quarters of 2024. This was driven by a one-time benefit of $14 million from the Employee Retention Credit associated with the CARES Act in the first three quarters of 2024, inventory write-downs of $8 million within Industrial and Military Aircraft in the first three quarters of 2025 and an $8 million out-of-period adjustment related to warranty expense in Commercial Aircraft in the first quarter of 2025.

Research and development expenses decreased in the third quarter and in the first three quarters of 2025 compared to the third quarter and the first three quarters of 2024 due to lower level of activity, primarily in Industrial.

Asset impairment and restructuring changes in the third quarter and the first three quarters of 2025 included an impairment in Industrial, charges for various simplification activities, primarily within Industrial, and charges associated with the termination of a product development effort in Military Aircraft. Asset impairment and restructuring changes in the third quarter and the first three quarters of 2024 included charges related to simplification initiatives, primarily in Industrial and Military Aircraft, and an impairment in Military Aircraft.

The effective tax rates in the third quarter of 2025 and in the first three quarters of 2025 were higher compared to the third quarter of 2024 and the first three quarters of 2024. The third quarter of 2024 and first three quarters of 2024 included higher benefits of favorable provision to return adjustments for tax credits associated with the respective prior year's tax returns.

The twelve-month backlog increased in the third quarter of 2025 compared with the third quarter of 2024. Within Space and Defense, we had higher orders across the entire portfolio of the business, reflecting strong business capture and broad-based growth in both Space and Defense. The twelve-month backlog in Military Aircraft increased due to the timing of orders across legacy and new OEM programs. The twelve-month backlog in Industrial increased due to changes in foreign currency exchange rates, partially offset by divestitures. Commercial Aircraft twelve-month backlog decreased in the third quarter of 2025. The timing of commercial OEM orders decreased backlog, partially offset by orders associated with increased amounts of long-term contracts in commercial aftermarket.

------

<u>[**Table of Contents**](#ie7d2cf4f294a4c48b9da5fb075e0f93b_7)</u>

**SEGMENT RESULTS OF OPERATIONS**

Operating profit, as presented below, is net sales less cost of sales and other operating expenses, excluding interest expense, equity-based compensation expense, non-service pension expense and other corporate expenses. Cost of sales and other operating expenses are directly identifiable to the respective segment or allocated on the basis of sales, headcount or profit. Operating profit is reconciled to earnings before income taxes in Note 20 - Segments in the Notes to Consolidated Condensed Financial Statements included in this report.

**Space and Defense**

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | Three Months Ended | Three Months Ended | Three Months Ended | Three Months Ended | Nine Months Ended | Nine Months Ended | Nine Months Ended | Nine Months Ended |
| (dollars in millions) | June 28, 2025 | June 29, 2024 | $ Variance | % Variance | June 28, 2025 | June 29, 2024 | $ Variance | % Variance |
| Net sales | $288 | $258 | $29 | 11% | $806 | $755 | $50 | 7% |
| Operating profit | $38 | $33 | $6 | 17% | $100 | $100 | $(1) | (1%) |
| Operating margin | *13.3 %* | *12.6 %* |  |  | *12.4 %* | *13.3 %* |  |  |

---

Space and Defense net sales increased in the third quarter and in the first three quarters of 2025 compared to the third quarter and first three quarters of 2024, reflecting broad-based defense demand. Higher demand for components for satellites and missiles was partially offset by timing of activity on spacecraft vehicles and turrets.

Operating margin increased in the third quarter of 2025 compared to the third quarter of 2024, driven by strong sales growth and a favorable sales mix. This was partially offset by investments we made for product development and business capture, as we continue to see large opportunities across both land and space applications.

Operating margin decreased in the first three quarters of 2025 compared to the first three quarters of 2024. In the first three quarters of 2025, we incurred $4 million of restructuring and other charges. Excluding these charges, operating margin was 12.9%. The resulting decrease in operating margin was due to the one-time benefit from the Employee Retention Credit associated with the CARES Act in the second quarter of 2024, partially offset by strong sales growth and a favorable sales mix through the first three quarters of 2025.

**Military Aircraft**

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | Three Months Ended | Three Months Ended | Three Months Ended | Three Months Ended | Nine Months Ended | Nine Months Ended | Nine Months Ended | Nine Months Ended |
| (dollars in millions) | June 28, 2025 | June 29, 2024 | $ Variance | % Variance | June 28, 2025 | June 29, 2024 | $ Variance | % Variance |
| Net sales | $225 | $207 | $17 | 8% | $652 | $596 | $56 | 9% |
| Operating profit | $18 | $24 | $(6) | (25%) | $65 | $60 | $4 | 7% |
| Operating margin | *8.0 %* | *11.6 %* |  |  | *9.9 %* | *10.1 %* |  |  |

---

Military Aircraft net sales increased in the third quarter and in the first three quarters of 2025 compared to the third quarter and first three quarters of 2024.

In the third quarter of 2025 and in the first three quarters of 2025, sales increased in military OEM programs $16 million and $53 million, respectively, driven by the ramp-up of activity on the FLRAA program and our new production work.

Operating margin decreased in the third quarter of 2025 compared to the third quarter of 2024. In the third quarter of 2025, we incurred an $8 million charge associated with the termination of a product development effort. Excluding this charge, operating margin was 11.6%. The resulting decrease in operating margin was due to investing more in research and development, as well as an unfavorable sales mix.

Operating margin decreased in the first three quarters of 2025 compared to the first three quarters of 2024. In the first three quarters of 2025, we incurred an $8 million charge associated with the termination of a product development effort in the third quarter and $3 million of other charges in previous quarters. In the first three quarters of 2024, we incurred $6 million of impairment charges and $5 million of restructuring and other charges. Excluding these charges, in the first three quarters of 2025 and first three quarters of 2024, operating margins were 11.5% and 12.0%, respectively. The resulting decrease in operating margin was due to the one-time benefit from the Employee Retention Credit in the second quarter of 2024 and the absence of the prior year's gain from the sale of a mature product line.

------

<u>[**Table of Contents**](#ie7d2cf4f294a4c48b9da5fb075e0f93b_7)</u>

**Commercial Aircraft**

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | Three Months Ended | Three Months Ended | Three Months Ended | Three Months Ended | Nine Months Ended | Nine Months Ended | Nine Months Ended | Nine Months Ended |
| (dollars in millions) | June 28, 2025 | June 29, 2024 | $ Variance | % Variance | June 28, 2025 | June 29, 2024 | $ Variance | % Variance |
| Net sales | $219 | $189 | $30 | 16% | $657 | $591 | $66 | 11% |
| Operating profit | $33 | $24 | $8 | 34% | $82 | $70 | $13 | 18% |
| Operating margin | *14.9 %* | *12.9 %* |  |  | *12.5 %* | *11.8 %* |  |  |

---

Commercial Aircraft net sales increased in the third quarter and in the first three quarters of 2025 compared to the third quarter and first three quarters of 2024.

In the third quarter of 2025, commercial aftermarket sales increased $29 million, driven largely by strong fleet utilization on the 787 and A350 programs. Commercial OEM sales increased $1 million, as the sale of intellectual property and inventory associated with a non-core product line was partially offset by decreased sales related to production delays certain customers are experiencing.

In the first three quarters of 2025, commercial aftermarket sales increased $58 million, and commercial OEM sales increased $8 million, both due largely to the same factors as the third quarter.

Operating margin increased in the third quarter of 2025 compared to the third quarter of 2024, driven by the sale of a non-core product line and record-level aftermarket sales. These factors were partially offset by pressure associated with tariffs and an unfavorable sales mix within our OEM business related to production delays certain customers are experiencing. Operating margin increased in the first three quarters of 2025 compared to the first three quarters of 2024, driven by the same factors as the third quarter, partially offset by an $8 million out-of-period adjustment related to warranty expense in the first quarter.

**Industrial**

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | Three Months Ended | Three Months Ended | Three Months Ended | Three Months Ended | Nine Months Ended | Nine Months Ended | Nine Months Ended | Nine Months Ended |
| (dollars in millions) | June 28, 2025 | June 29, 2024 | $ Variance | % Variance | June 28, 2025 | June 29, 2024 | $ Variance | % Variance |
| Net sales | $240 | $250 | $(10) | (4%) | $702 | $749 | $(47) | (6%) |
| Operating profit | $23 | $24 | $(1) | (6%) | $76 | $82 | $(6) | (7%) |
| Operating margin | *9.6 %* | *9.8 %* |  |  | *10.8 %* | *10.9 %* |  |  |

---

Industrial net sales decreased in the third quarter of 2025 compared to the third quarter of 2024, driven by the lost sales associated with our divestitures we completed at the beginning of this fiscal year.

In the first three quarters of 2025 compared to the first three quarters of 2024, divestitures as well as purposeful product and customer exits reduced sales, primarily within industrial automation, which decreased $44 million. In addition, lower sales for simulation and test products, following a prior year record, was mostly offset by market share gains for medical devices.

Operating margin decreased in the third quarter of 2025 compared to the third quarter of 2024. The third quarter of 2025 included inventory write-downs of $4 million, an asset impairment of $3 million and restructuring charges of $2 million. The third quarter of 2024 included restructuring charges of $3 million and inventory write-downs of $2 million. Excluding the impacts of these charges, operating margins in the third quarters of 2025 and 2024 were 13.5% and 11.7%, respectively. The resulting increase in operating margin was primarily due to simplification initiatives, partially offset by pressure associated with tariffs.

Operating margin decreased in the first three quarters of 2025 compared to the first three quarters of 2024. The first three quarters of 2025 included restructuring and other charges of $9 million, inventory write-downs of $6 million and an asset impairment of $3 million. The first three quarters of 2024 included restructuring charges of $9 million and inventory write-downs of $2 million. Excluding the impacts of these charges, operating margins in the first three quarters of 2025 and 2024 were 13.4% and 12.3%, respectively. The resulting increase in operating margin was primarily due to simplification initiatives, which was partially offset by the one-time benefit from the Employee Retention Credit in the second quarter of 2024.

------

<u>[**Table of Contents**](#ie7d2cf4f294a4c48b9da5fb075e0f93b_7)</u>

**LIQUIDITY AND CAPITAL RESOURCES**

**Consolidated Statements of Cash Flows**

---

| | | | |
|:---|:---|:---|:---|
| | Nine Months Ended | Nine Months Ended | Nine Months Ended |
| (dollars in millions) | June 28,<br>2025 | June 29,<br>2024 | $ Variance |
| Net cash provided (used) by: |  |  |  |
| Operating activities | $32 | $47 | $(14) |
| Investing activities | (92) | (115) | 22 |
| Financing activities | 55 | 51 | 4 |

---

**Operating activities**

Net cash from operating activities in the first three quarters of 2025 provided less cash than net cash provided by operating activities in the first three quarters of 2024. Accounts receivable used $87 million more cash, driven by the timing of collections. The timing of income tax payments used $33 million more cash. These uses were partially offset by physical inventories, which used $64 million less cash, as the growth of physical inventories slowed in Space and Defense, Military Aircraft and Commercial Aircraft. Also, customer advances provided $36 million more cash, as we secured customer advances on multiple defense programs.

**Investing activities**

Net cash used by investing activities in the first three quarters of 2025 included $103 million of capital expenditures for investments in organic growth, which was partially offset by $13 million of proceeds from the sales of businesses.

Net cash used by investing activities in the first three quarters of 2024 included $110 million of capital expenditures and $6 million associated with the acquisition of DCL.

**Financing activities**

Net cash provided by financing activities in the first three quarters of 2025 included $206 million of net borrowings on our credit facilities. Financing activities included a use of cash of $100 million for shares under the repurchase program authorized by the Board of Directors, which is a component of the purchase of outstanding shares for treasury, and $27 million of cash dividends.

Net cash provided by financing activities in the first three quarters of 2024 included $94 million of net borrowings on our credit facilities. Financing activities included a use of cash of $27 million of cash dividends.

**General**

Cash flows from our operations, together with our various financing arrangements, fund on-going activities, debt service requirements, organic growth, acquisition opportunities and the ability to return capital to shareholders. We believe these sources of funding will be sufficient to meet our cash requirements for the next 12 months and for the foreseeable future thereafter.

At June 28, 2025, our cash balances were $59 million, the majority of which is held outside of the U.S. by foreign operations. We regularly assess our cash needs, including repatriation of foreign earnings which may be subject to regulatory approvals and withholding taxes, where applicable by law.

**Financing Arrangements**

In addition to operations, our capital resources include bank credit facilities and an accounts receivable financing program to fund our short and long-term capital requirements. We continuously evaluate various forms of financing to improve our liquidity and position ourselves for future opportunities, which, from time to time, may result in selling debt and equity securities to fund acquisitions or take advantage of favorable market conditions.

We are generally not required to obtain the consent of lenders of the U.S. revolving credit facility before raising significant additional debt financing; however, certain limitations and conditions may apply that would require consent to be obtained. We have demonstrated our ability to secure consents to access debt markets. We have also been successful in accessing equity markets from time to time. We believe that we will be able to obtain additional debt or equity financing as needed.

------

<u>[**Table of Contents**](#ie7d2cf4f294a4c48b9da5fb075e0f93b_7)</u>

In the normal course of business, we are exposed to interest rate risk from our long-term debt. To manage these risks, we may enter into derivative instruments such as interest rate swaps which are used to adjust the proportion of total debt that is subject to variable and fixed interest rates.

Our U.S. revolving credit facility, which matures on October 27, 2027, has a capacity of $1.1 billion and also provides an expansion option, which permits us to request an increase of up to $400 million to the credit facility upon satisfaction of certain conditions. The weighted-average interest rate on the outstanding U.S. revolving credit facility borrowings was 5.92% and is based on SOFR plus the applicable margin, which was 1.60% at June 28, 2025. On May 30, 2025, we amended and restated our loan agreement to include a $250 million term loan with installment payments of $3 million in 2026, $9 million in 2027 and the remaining balance on the maturity date of

October 27, 2027. Additional principal payments may be required under certain conditions. The proceeds of the term loan were used to pay down the outstanding revolver borrowings of the U.S. revolving credit facility. The interest rate on the term loan borrowings was 5.93% and is based on SOFR plus the applicable margin, which was 1.60% at June 28, 2025.

The loan agreement for the U.S. revolving credit facility and term loan contains various covenants. The minimum for the interest coverage ratio, defined as the ratio of EBITDA to interest expense for the most recent four quarters, is 3.0. The maximum for the leverage ratio, defined as the ratio of net debt to EBITDA for the most recent four quarters, is 4.0. EBITDA is defined in the loan agreement as (i) the sum of net income, interest expense, income taxes, depreciation expense, amortization expense, other non-cash items reducing consolidated net income and non-cash equity-based compensation expenses minus (ii) other non-cash items increasing consolidated net income.

The SECT has a revolving credit facility with a borrowing capacity of $25 million, maturing on October 26, 2026. Interest was 6.54% as of June 28, 2025 and is based on SOFR plus a margin of 2.23%.

We have $500 million aggregate principal amount of 4.25% senior notes due December 15, 2027 with interest paid semiannually on June 15 and December 15 of each year. The senior notes are unsecured obligations, guaranteed on a senior unsecured basis by certain subsidiaries and contain normal incurrence-based covenants and limitations such as the ability to incur additional indebtedness, pay dividends, make other restricted payments and investments, create liens and certain corporate acts such as mergers and consolidations.

At June 28, 2025, we had $790 million of unused capacity, including $766 million from the U.S. revolving credit facility after considering standby letters of credit and other limitations.

Our Receivables Purchase Agreement, which matures on December 11, 2026, allows the Receivables Subsidiary to sell receivables to the Purchasers in amounts up to a $125 million limit so long as certain conditions are satisfied. The receivables are sold to the Purchasers in consideration for the Purchasers making payments of cash. Each Purchaser's share of capital accrues yield at a variable rate plus an applicable margin, which totaled 5.38% as of June 28, 2025.

We are in compliance with all covenants under each of our financing arrangements. See Note 4 - Receivables and Note 10 – Indebtedness, of Part I, Item 1, Financial Information of this report for additional details.

**Dividends and Common Stock**

We believe we can create long term value for our shareholders by continuing to invest in our business through both capital expenditures as well as investments in new market opportunities. We will also continue exploring opportunities to make strategic acquisitions and return capital to shareholders.

We are currently paying quarterly cash dividends on our Class A and Class B common stock and expect to continue to do so for the foreseeable future. See the Consolidated Condensed Statement of Shareholders Equity and Cash Flows, of Part I, Item 1, Financial Information, of this report for additional details.

------

<u>[**Table of Contents**](#ie7d2cf4f294a4c48b9da5fb075e0f93b_7)</u>

The Board of Directors authorized a share repurchase program that permits repurchases for both Class A and Class B common stock, and allows us to buy up to an aggregate 3 million common shares. There are approximately 1.7 million common shares remaining under this authorization. See the Consolidated Condensed Statement of Shareholders Equity and Cash Flows, of Part I, Item 1, Financial Information and Part II, Item 2, Unregistered Sales of Equity Securities and Use of Proceeds, of this report for additional details.

**Off Balance Sheet Arrangements**

We do not have any material off balance sheet arrangements that have or are reasonably likely to have a material future effect on our financial condition, results of operations or cash flows.

**Contractual Obligations and Commercial Commitments**

Our contractual obligations and commercial commitments have not changed materially from the disclosures in our Annual Report on Form 10-K for the year ended September 28, 2024. See Note 7 - Leases, Note 10 - Indebtedness, Note 15 - Employee Benefit Plans and Note 22 - Commitments and Contingencies, of Part I, Item 1, Financial Information, of this report for additional details.

**ECONOMIC CONDITIONS AND MARKET TRENDS**

We operate within the aerospace and defense market and the industrial market. A common factor throughout our markets is the continuing demand for technologically advanced products.

Our aerospace and defense businesses represented 73% of our 2024 sales. Our defense market, which represented 51% of our 2024 sales, is directly affected by defense funding levels and product demand, which have recently increased. Our commercial aircraft market, which represented 22% of our 2024 sales, is aligning with our customers' current plans. Within our various industrial markets, which collectively represented 27% of our 2024 sales, our customers are affected by a broad range of factors.

**Aerospace and Defense**

Within aerospace and defense, we serve three end markets: defense, commercial aircraft and space.

The defense market is dependent on military spending for development and production programs. We have a growing development program order book for future generation aircraft and turret programs, and we strive to embed our technologies within these high-performance military programs of the future, including the Textron Bell MV-75 FLRAA. Aircraft production programs are typically long-term in nature, offering predictable capacity needs and future revenues. We maintain positions on numerous high priority programs, including the Lockheed Martin F-35 Lightning II. The large installed base of our products leads to attractive aftermarket sales and service opportunities. The tactical and strategic missile, missile defense and defense controls markets are dependent on many of the same market conditions as military aircraft, including overall military spending and program funding levels. At times when there are perceived threats to national security, U.S. and European defense spending can increase; at other times, defense spending can decrease. Future levels of defense spending have increased in the near-term given the current global tensions, and are subject to governmental approvals.

The commercial OEM aircraft market depends on a number of factors, including both the increasing global demand for air travel and increasing fuel prices. Both factors contributed to the demand for new, more fuel-efficient aircraft with lower operating costs that led to large production backlogs for Boeing and Airbus. Boeing and Airbus are producing widebody aircraft at rates to support their projected demand while working through their current supply-chain constraints. Any adjustments to their production rates affect the timing of the demand for our flight control systems.

The commercial aftermarket is driven by usage and the age of the existing aircraft fleet for passenger and cargo aircraft, which drives the need for maintenance and repairs. We have seen higher demand levels for our maintenance services and spare parts due to the increased number of flight hours across existing fleets.

------

<u>[**Table of Contents**](#ie7d2cf4f294a4c48b9da5fb075e0f93b_7)</u>

The space market is comprised of three customer markets: civil, U.S. Department of Defense and commercial space. The civil market, namely NASA, is driven by investment for exploration activities. The U.S. Department of Defense market is driven by government-authorized levels of defense spending, including funding for defense-related satellite and space vehicle technologies. Levels of U.S. defense spending could increase as there is growing emphasis on space as the next frontier of potential future conflicts. The commercial space market is driven by demand for small satellites, which increases the demand for increased launch vehicle capacity. Our launch vehicle and satellite components and systems will continue to benefit from increased investments in each of these markets.

**Industrial**

Within industrial, we serve two end markets: industrial and medical. The industrial market consists of industrial automation products, simulation and test products and energy generation and exploration products. The medical market consists of medical devices and medical component products.

The industrial market we serve with our industrial automation products is influenced by several factors including capital investment levels, the pace of product and technology innovation, economic conditions and cost-reduction efforts. A portion of our industrial automation customers serve the automotive market.

Our simulation and test products operate in markets that were largely affected by the same factors and investment challenges as our commercial aircraft market. We will see stronger order demand for flight simulation systems as the airline training market grows in line with domestic and foreign flight hours.

Our energy generation and exploration products operate in a market that is influenced by changing oil and natural gas prices, global urbanization and the resulting change in supply and demand for global energy. Historically, drivers for global growth include investments in power generation infrastructure and exploration of new oil and gas resources.

The medical market we serve, in general, is influenced by economic conditions, regulatory environments, hospital and outpatient clinic spending on equipment, population demographics, medical advances, patient demands and the need for precision control components and systems. Advances in medical technology and treatments have resulted in the greater need for medical services, which drive the demand for our medical devices and components programs.

**Foreign Currencies**

We are affected by the movement of foreign currencies compared to the U.S. dollar. About one-sixth of our 2024 sales were denominated in foreign currencies. During the first nine months of 2025, average foreign currency rates generally were the same against the U.S. dollar compared to 2024. The translation of the results of our foreign subsidiaries into U.S. dollars had no material impact on sales compared to the same period one year ago.

------

<u>[**Table of Contents**](#ie7d2cf4f294a4c48b9da5fb075e0f93b_7)</u>

**Cautionary Statement**

Information included or incorporated by reference in this report contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, which can be identified by words such as: "may," "will," "should," "believes," "expects," "expected," "intends," "plans," "projects," "approximate," "estimates," "predicts," "potential," "outlook," "forecast," "anticipates," "presume," "assume" and other words and terms of similar meaning (including their negative counterparts or other various or comparable terminology). These forward-looking statements are made pursuant to the Private Securities Litigation Reform Act of 1995, are neither historical facts nor guarantees of future performance and are subject to several factors, risks and uncertainties, the impact or occurrence of which could cause actual results to differ materially from the expected results described in the forward-looking statements.

Although it is not possible to create a comprehensive list of all factors that may cause our actual results to differ from the results expressed or implied by our forward-looking statements or that may affect our future results, some of these factors and other risks and uncertainties are described in Item 1A "Risk Factors" of our Annual Report on Form 10-K and in our other periodic filings with the Securities and Exchange Commission ("SEC") and include, but are not limited to, risks relating to: (i) our operation in highly competitive markets with competitors who may have greater resources than we possess; (ii) our operation in cyclical markets that are sensitive to domestic and foreign economic conditions and events; (iii) our heavy dependence on government contracts that may not be fully funded or may be terminated; (iv) supply chain constraints and inflationary impacts on prices for raw materials and components used in our products; (v) failure of our subcontractors or suppliers to perform their contractual obligations; and (vi) our accounting estimations for over-time contracts and any changes we need to make thereto. You should evaluate all forward-looking statements made in this report in the context of these risks and uncertainties.

While we believe we have identified and discussed in our SEC filings the material risks affecting our business, there may be additional factors, risks and uncertainties not currently known to us or that we currently consider immaterial that may affect the forward-looking statements we make herein. Given these factors, risks and uncertainties, investors should not place undue reliance on forward-looking statements as predictive of future results. Any forward-looking statement speaks only as of the date on which it is made, and we disclaim any obligation to update any forward-looking statement made in this report, except as required by applicable law.

**Item 3. Quantitative and Qualitative Disclosures about Market Risk.**

Refer to the Company's Annual Report on Form 10-K for the year ended September 28, 2024 for a complete discussion of our market risk. There have been no material changes in the current year regarding this market risk information.

**Item 4. Controls and Procedures.**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)Disclosure Controls and Procedures. We carried out an evaluation, under the supervision and with the participation of our management, including the Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures as defined in Exchange Act Rules 13a-15(e) and 15d-15(e). Based on that evaluation, the Chief Executive Officer and Chief Financial Officer concluded that these disclosure controls and procedures are effective as of June 28, 2025 to ensure that information required to be disclosed in reports filed or submitted under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission's rules and forms, and that such information is accumulated and communicated to management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosures.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)Changes in Internal Control over Financial Reporting. There have been no changes during the most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

------

<u>[**Table of Contents**](#ie7d2cf4f294a4c48b9da5fb075e0f93b_7)</u>

**PART II OTHER INFORMATION**

**Item 1A. Risk Factors.**

Refer to the Company's Annual Report on Form 10-K for the year ended September 28, 2024 for a complete discussion of our risk factors. There have been no material changes in the current year regarding our risk factors.

------

**Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.**

(c)The following table summarizes our purchases of our common stock for the quarter ended June 28, 2025.

---

| | | | | |
|:---|:---|:---|:---|:---|
| Period | (a) Total<br>Number of<br>Shares<br>Purchased (1) (2)(3) | (b) Average<br>Price Paid<br>Per Share (4) | (c) Total number<br>of Shares<br>Purchased as<br>Part of Publicly<br>Announced Plans<br>or Programs (3) | (d) Maximum Number<br>(or Approx.<br>Dollar Value) of<br>Shares that May<br>Yet Be Purchased<br>Under Plans or<br>Programs (3) |
| March 30, 2025 - April 26, 2025 | 14019 | $167.06 |  | 1660107 |
| April 27, 2025 - May 31, 2025 | 9140 | 175.31 |  | 1660107 |
| June 1, 2025 - June 28, 2025 | 6204 | 183.08 |  | 1660107 |
| Total | 29363 | $173.01 |  | 1660107 |

---

During the quarter ended June 28, 2025, no director or officer of the Company adopted or terminated a "Rule 10b 5-1 trading arrangement" or "Non-Rule 10b 5-1 trading arrangement," as each term is defined in item 408 of Regulation S-K.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)Reflects purchases by the SECT of shares of Class B common stock from the ESPP, the RSP and from equity-based compensation award recipients under right of first refusal terms at average prices as follows: 12,309 shares at $166.73 in April, 2,951 shares at $172.47 in May and 6,204 shares at $183.08 in June.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)In connection with the exercise of equity-based compensation awards, we accept delivery of shares to pay for the exercise price and withhold shares for tax withholding obligations at average prices as follows: In May we accepted delivery of 2,282 Class B shares at $168.84. In connection with the issuance of equity-based awards and shares to the ESPP, we purchased 1,710 Class B shares at $169.45 per share from the SECT in April and 3,907 Class B shares at $181.23 in May.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3)The Board of Directors has authorized a share repurchase program that permits the purchase of up to 3 million common shares of Class A or Class B common stock in open market or privately negotiated transactions at the discretion of management. No shares were purchased under the program for the quarter ended June 28, 2025.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(4)Excludes 1% excise tax accrued pursuant to the Inflation Reduction Act of 2022.

------

<u>[**Table of Contents**](#ie7d2cf4f294a4c48b9da5fb075e0f93b_7)</u>

**Item 6. Exhibits.**

---

| | | | |
|:---|:---|:---|:---|
| (a) | Exhibits | Exhibits |  |
|  | <u>[31.1](exhibit311jul2525.htm)</u> | Certification of Chief Executive Officer pursuant to Exchange Act Rule 13a-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | Certification of Chief Executive Officer pursuant to Exchange Act Rule 13a-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. |
|  | <u>[31.2](exhibit312jul2525.htm)</u> | Certification of Chief Financial Officer pursuant to Exchange Act Rule 13a-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | Certification of Chief Financial Officer pursuant to Exchange Act Rule 13a-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. |
|  | <u>[32.1](exhibit321jul2525.htm)</u> | Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. | Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. |
|  | 101 | Interactive Date files (submitted electronically herewith) | Interactive Date files (submitted electronically herewith) |
|  |  | (101.INS) | XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. |
|  |  | (101.SCH) | XBRL Taxonomy Extension Schema Document |
|  |  | (101.CAL) | XBRL Taxonomy Extension Calculation Linkbase Document |
|  |  | (101.DEF) | XBRL Taxonomy Extension Definition Linkbase Document |
|  |  | (101.LAB) | XBRL Taxonomy Extension Label Linkbase Document |
|  |  | (101.PRE) | XBRL Taxonomy Extension Presentation Linkbase Document |
|  | 104 | Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document and are contained within Exhibit 101. | Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document and are contained within Exhibit 101. |

---

------

<u>[**Table of Contents**](#ie7d2cf4f294a4c48b9da5fb075e0f93b_7)</u>

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

---

| | | | |
|:---|:---|:---|:---|
| | | | Moog Inc. |
| | | | (Registrant) |
| Date: | <u>July 25, 2025</u> | By | /s/ Pat Roche |
|  |  |  | Pat Roche |
|  |  |  | Chief Executive Officer<br>(Principal Executive Officer) |
| Date: | <u>July 25, 2025</u> | By | /s/ Jennifer Walter |
|  |  |  | Jennifer Walter |
|  |  |  | Chief Financial Officer<br>(Principal Financial Officer) |
| Date: | <u>July 25, 2025</u> | By | /s/ Nicholas Hart |
|  |  |  | Nicholas Hart |
|  |  |  | Controller<br>(Principal Accounting Officer) |

---

## Exhibit 31.1

**Exhibit 31.1**

**Certification of Chief Executive Officer pursuant to Exchange Act Rule 13a-14(a) as adopted** 

**pursuant to Section 302 of the Sarbanes-Oxley Act of 2002**

I, Pat Roche, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Moog Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a) &nbsp;&nbsp;&nbsp;&nbsp;Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b) &nbsp;&nbsp;&nbsp;&nbsp;Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c)Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d) &nbsp;&nbsp;&nbsp;&nbsp;Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of registrant's board of directors (or persons performing equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date&nbsp;&nbsp;&nbsp;&nbsp;<u>July 25, 2025</u> 

<u>/s/ Pat Roche</u> 

Pat Roche

Chief Executive Officer

## Exhibit 31.2

**Exhibit 31.2**

**Certification of Chief Financial Officer pursuant to Exchange Act Rule 13a-14(a) as adopted** 

**pursuant to Section 302 of the Sarbanes-Oxley Act of 2002**

I, Jennifer Walter, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Moog Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a) &nbsp;&nbsp;&nbsp;&nbsp;Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b) &nbsp;&nbsp;&nbsp;&nbsp;Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c)Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d) &nbsp;&nbsp;&nbsp;&nbsp;Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of registrant's board of directors (or persons performing equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date&nbsp;&nbsp;&nbsp;&nbsp;<u>July 25, 2025</u> 

<u>/s/ Jennifer Walter</u> 

Jennifer Walter

Chief Financial Officer

## Exhibit 32.1

**Exhibit 32.1**

&nbsp;&nbsp;&nbsp;&nbsp;

**Certification pursuant to** 

**18 U.S.C. Section 1350,** 

**as adopted pursuant to** 

**Section 906 of the Sarbanes-Oxley Act of 2002**

Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officers of Moog Inc. (the "Company") hereby certify that:

The Company's Quarterly Report on Form 10-Q for the quarter ended June 28, 2025 fully complies with the requirements of section 13(a) or 15(d) of the Securities and Exchange Act of 1934 and the information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated: <u>July 25, 2025</u> 

<u>/s/ Pat Roche</u> 

Pat Roche

Chief Executive Officer

<u>/s/ Jennifer Walter</u> 

Jennifer Walter

Chief Financial Officer

This certification shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liability of that section. This certification shall not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except to the extent specifically incorporated by the Company into such filing.

<br>